Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	minor groove of adenine-thymine-rich DNA binding	MAPT POU3F4 KMT2A	7.09e-05	11	154	3	GO:0003680
GeneOntologyBiologicalProcess	embryonic morphogenesis	ALX3 COL5A2 TCF3 DLL4 NAGLU POU3F4 ARID1A AHDC1 LHX1 HOXA13 C2CD3 LATS2 LDB1 PITX1 TSHZ1 TAL1 YTHDF2 FOXF1 TBX5	9.74e-07	713	149	19	GO:0048598
GeneOntologyBiologicalProcess	cerebellar Purkinje cell-granule cell precursor cell signaling	LHX1 LHX5	5.18e-05	2	149	2	GO:0021937
GeneOntologyBiologicalProcess	animal organ morphogenesis	ALX3 COL5A2 ATG9B DLL4 NAGLU APC POU3F4 GATA5 ZMIZ1 ARID1A PGF AHDC1 SLC4A2 LHX1 HOXA13 NCOR2 FAT1 C2CD3 TLE3 TSHZ1 FOXF1 TBX5	1.17e-04	1269	149	22	GO:0009887
GeneOntologyBiologicalProcess	spinal cord association neuron differentiation	LHX1 LHX5 TAL1	1.27e-04	14	149	3	GO:0021527
GeneOntologyBiologicalProcess	gastrulation	COL5A2 TCF3 ARID1A AHDC1 LHX1 LDB1 TAL1 FOXF1	1.57e-04	212	149	8	GO:0007369
GeneOntologyBiologicalProcess	protein localization to centrosome	APC NUDCD3 KIAA0753 C2CD3	1.59e-04	38	149	4	GO:0071539
GeneOntologyBiologicalProcess	protein localization to microtubule organizing center	APC NUDCD3 KIAA0753 C2CD3	1.77e-04	39	149	4	GO:1905508
GeneOntologyBiologicalProcess	cerebellar Purkinje cell layer development	NAGLU LHX1 LDB1 LHX5	1.77e-04	39	149	4	GO:0021680
GeneOntologyBiologicalProcess	cell fate commitment	TCF3 DLL4 OTUD5 APC GATA5 HOXA13 LATS2 PITX1 TAL1 TBX5	1.79e-04	338	149	10	GO:0045165
GeneOntologyBiologicalProcess	central nervous system neuron differentiation	DLL4 MAPT POU3F4 ZMIZ1 LHX1 LDB1 LHX5 TAL1	1.85e-04	217	149	8	GO:0021953
GeneOntologyBiologicalProcess	leukocyte differentiation	TCF3 ZC3H12A DLL4 OTUD5 NAGLU APC GON4L ZMIZ1 ARID1A IFI16 SLC4A2 JMJD6 GPR137B KMT2A LYL1 TAL1	1.93e-04	789	149	16	GO:0002521
GeneOntologyBiologicalProcess	regulation of chromatin organization	RLF TLK1 KMT2A TAL1	1.95e-04	40	149	4	GO:1902275
GeneOntologyBiologicalProcess	mononuclear cell differentiation	TCF3 ZC3H12A DLL4 OTUD5 NAGLU APC GON4L ZMIZ1 ARID1A IFI16 SLC4A2 JMJD6 KMT2A LYL1	2.30e-04	640	149	14	GO:1903131
GeneOntologyBiologicalProcess	heart valve development	DLL4 NAGLU APC GATA5 TBX5	2.54e-04	78	149	5	GO:0003170
GeneOntologyBiologicalProcess	embryo development	ALX3 COL5A2 TCF3 DLL4 NAGLU POU3F4 ZMIZ1 ARID1A AHDC1 LHX1 HOXA13 NCOR2 C2CD3 LATS2 LDB1 PITX1 KMT2A TSHZ1 TAL1 YTHDF2 FOXF1 PRRC2B TBX5	2.60e-04	1437	149	23	GO:0009790
GeneOntologyBiologicalProcess	cerebellar Purkinje cell differentiation	LHX1 LDB1 LHX5	2.78e-04	18	149	3	GO:0021702
GeneOntologyBiologicalProcess	formation of primary germ layer	COL5A2 ARID1A AHDC1 LHX1 TAL1 FOXF1	2.85e-04	124	149	6	GO:0001704
GeneOntologyCellularComponent	beta-catenin-TCF complex	BCL9 LDB1 TLE3 TLE4	1.92e-06	13	154	4	GO:1990907
MousePheno	abnormal B cell differentiation	TCF3 ZC3H12A GON4L NUDCD3 IGLL5 COG6 TLE4 KMT2A ZC3H12C LYL1 SPEN	4.53e-05	287	123	11	MP:0002144
MousePheno	rostral-caudal axis duplication	APC LHX1 LDB1	5.37e-05	9	123	3	MP:0012156
MousePheno	abnormal hematopoietic stem cell morphology	TCF3 ARID1A NCOR2 TLE4 KMT2A TACC3 TAL1	5.80e-05	112	123	7	MP:0004808
MousePheno	abnormal pro-B cell morphology	TCF3 GON4L IGLL5 TLE4 KMT2A LYL1	6.29e-05	78	123	6	MP:0005432
MousePheno	abnormal cardiovascular development	DLL4 APC GATA5 ZMIZ1 ARID1A PGF AHDC1 HOXA13 NCOR2 C2CD3 LDB1 ADAMTS7 COG6 ARHGEF4 SPEN TAL1 FOXF1 PRRC2B TBX5	7.15e-05	802	123	19	MP:0002925
MousePheno	abnormal female urethra morphology	GATA5 HOXA13	7.68e-05	2	123	2	MP:0011780
Domain	RNase_Zc3h12a	ZC3H12A ZC3H12B ZC3H12D ZC3H12C	1.37e-07	7	150	4	PF11977
Domain	RNase_Zc3h12_NYN	ZC3H12A ZC3H12B ZC3H12D ZC3H12C	1.37e-07	7	150	4	IPR021869
Domain	NCKAP5_C	NCKAP5 NCKAP5L	6.41e-05	2	150	2	IPR032769
Domain	Nckap5l	NCKAP5 NCKAP5L	6.41e-05	2	150	2	IPR026163
Domain	NCKAP5	NCKAP5 NCKAP5L	6.41e-05	2	150	2	PF15246
Domain	BAH	BAHD1 TNRC18 BAHCC1	7.99e-05	11	150	3	PS51038
Domain	BAH_dom	BAHD1 TNRC18 BAHCC1	7.99e-05	11	150	3	IPR001025
Domain	BAH	BAHD1 TNRC18 BAHCC1	7.99e-05	11	150	3	SM00439
Domain	BAH	BAHD1 TNRC18 BAHCC1	7.99e-05	11	150	3	PF01426
Domain	BAT2_N	PRRC2A PRRC2B	1.91e-04	3	150	2	PF07001
Domain	BAT2_N	PRRC2A PRRC2B	1.91e-04	3	150	2	IPR009738
Domain	PRRC2	PRRC2A PRRC2B	1.91e-04	3	150	2	IPR033184
Domain	Homeodomain-like	ALX3 TCF3 GON4L POU3F4 LHX1 HOXA13 NCOR2 PITX1 TSHZ1 LHX5	3.58e-04	332	150	10	IPR009057
Domain	Groucho_enhance	TLE3 TLE4	6.31e-04	5	150	2	IPR009146
Domain	TLE_N	TLE3 TLE4	6.31e-04	5	150	2	PF03920
Domain	Groucho/TLE_N	TLE3 TLE4	6.31e-04	5	150	2	IPR005617
Pathway	KEGG_MEDICUS_VARIANT_LMO2_REARRANGEMENT_TO_TRANSCRIPTIONAL_ACTIVATION	TCF3 LDB1 LYL1	3.33e-06	5	99	3	M48996
Pathway	KEGG_MEDICUS_VARIANT_LMO2_REARRANGEMENT_TO_TRANSCRIPTIONAL_REPRESSION	TCF3 LDB1 LYL1	3.33e-06	5	99	3	M48995
Pathway	REACTOME_RUNX1_REGULATES_TRANSCRIPTION_OF_GENES_INVOLVED_IN_DIFFERENTIATION_OF_HSCS	TCF3 PSMB1 LDB1 KMT2A TAL1	9.13e-05	65	99	5	MM15530
Pubmed	A dual-activity topoisomerase complex regulates mRNA translation and turnover.	DPH2 NAGLU MYOM3 CORO1B BCL9 MBD6 ARID1A AHDC1 BAHD1 RNF43 TIAM2 NCOR2 TLK1 FAT1 TNRC18 C2CD3 AATK LATS2 ADAMTS7 PITX1 NLRC5 TNKS1BP1 ARHGEF4 SSBP4 SPEN CEP170B PRRC2B ZNF687 RBM38 BAHCC1	2.91e-15	1105	158	30	35748872
Pubmed	Interaction network of human early embryonic transcription factors.	HIVEP1 ZMIZ1 BCL9 MBD6 ARID1A AHDC1 RLF NCOR2 TNRC18 LDB1 TLE3 TLE4 PITX1 KMT2A SPEN PRRC2B BAHCC1	6.01e-13	351	158	17	38297188
Pubmed	Large-scale characterization of HeLa cell nuclear phosphoproteins.	HIVEP1 OTUD5 MAPT BCL9 IFI16 NCOR2 TLK1 USP42 TLE3 PKP3 TLE4 SIPA1L1 EIF5B KMT2A TNKS1BP1 TACC3 SRRM2 SPEN MN1 PRRC2A ZNF687 PPP6R3	8.62e-12	774	158	22	15302935
Pubmed	Control of developmentally primed erythroid genes by combinatorial co-repressor actions.	TCF3 NCOR2 LDB1 SSBP4 LYL1 SPEN TAL1	6.51e-11	30	158	7	26593974
Pubmed	Human transcription factor protein interaction networks.	TCF3 ZNF326 HIVEP1 PSMB1 GON4L ZMIZ1 BCL9 MBD6 ARID1A RLF LHX1 NCOR2 FAT1 LDB1 TLE3 TLE4 PITX1 KMT2A SSBP4 SRRM2 SPEN TAL1 PRRC2A YTHDF2 PRRC2B ZNF687 PPP6R3	3.29e-10	1429	158	27	35140242
Pubmed	A novel CCCH-zinc finger protein family regulates proinflammatory activation of macrophages.	ZC3H12A ZC3H12B ZC3H12D ZC3H12C	4.10e-10	4	158	4	18178554
Pubmed	PRISMA and BioID disclose a motifs-based interactome of the intrinsically disordered transcription factor C/EBPα.	EEFSEC TCF3 HIVEP1 PSMB1 BCL9 ARID1A IFI16 AHDC1 RLF HOXA13 NCOR2 TLK1 TNRC18 TLE3 PITX1 EIF5B KMT2A SRRM2 SPEN PRRC2A PRRC2B ZNF687	6.51e-09	1103	158	22	34189442
Pubmed	TIF1gamma controls erythroid cell fate by regulating transcription elongation.	TCF3 LDB1 SSBP4 LYL1 TAL1	1.48e-08	18	158	5	20603019
Pubmed	Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing.	TCF3 RPH3AL PCDHGB1 MAPT NUDCD3 ZMIZ1 ARID1A CDC42EP3 AHDC1 RLF NCOR2 TLK1 TNRC18 LATS2 LDB1 COQ8A TLE3 PKP3 GPR137B NLRC5 ENPP5 IGSF9B ARHGEF4 PCDH1 CEP170B	1.69e-08	1489	158	25	28611215
Pubmed	Constitutive scaffolding of multiple Wnt enhanceosome components by Legless/BCL9.	BCL9 LDB1 TLE3 TLE4	2.83e-08	8	158	4	28296634
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: II. The complete nucleotide sequences of 400 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	NRCAM TSPOAP1 DDN GON4L JMJD6 TLE3 TLE4 SIPA1L1 ARHGEF4 SRRM2 SPEN CEP170B PRRC2B	5.10e-08	407	158	13	12693553
Pubmed	Differential use of SCL/TAL-1 DNA-binding domain in developmental hematopoiesis.	TCF3 LDB1 TAL1	9.20e-08	3	158	3	18550854
Pubmed	A genome-wide screen to identify transcription factors expressed in pelvic Ganglia of the lower urinary tract.	TCF3 ZNF326 ZNF219 HIVEP1 POU3F4 ARID1A RNF43 RLF LHX1 HOXA13 ST6GAL2 LDB1 KMT2A LHX5 TACC3 ZNF687	1.70e-07	709	158	16	22988430
Pubmed	Systematic bromodomain protein screens identify homologous recombination and R-loop suppression pathways involved in genome integrity.	ZNF219 MAPT PPFIA1 EMILIN3 ARID1A NCKAP5L RNF43 NCOR2 ZNF469 FAT1 COQ8A KMT5B JMJD6 SIPA1L1 SRRM2 CEP170B PRRC2B ZNF687 BAHCC1 BRWD1	1.89e-07	1116	158	20	31753913
Pubmed	Comparative Application of BioID and TurboID for Protein-Proximity Biotinylation.	ZNF326 AUP1 ZMIZ1 BCL9 ARID1A AHDC1 NCOR2 PRR14 TLE3 PKP3 FAM222B YTHDF2 PRRC2B	1.94e-07	457	158	13	32344865
Pubmed	Cutting Edge: Lymphomyeloid-Primed Progenitor Cell Fates Are Controlled by the Transcription Factor Tal1.	TCF3 LYL1 TAL1	3.67e-07	4	158	3	30962294
Pubmed	A central chaperone-like role for 14-3-3 proteins in human cells.	ZNF326 HIVEP1 MAPT PPFIA1 APC NCKAP5L MAP3K6 KIAA0753 C2CD3 MAST4 SIPA1L1 KMT2A TNKS1BP1 ARHGEF4 SRRM2 YTHDF2 CEP170B	4.45e-07	861	158	17	36931259
Pubmed	Proximity-dependent Mapping of the Androgen Receptor Identifies Kruppel-like Factor 4 as a Functional Partner.	HIVEP1 BCL9 ARID1A AHDC1 TNRC18 LDB1 TLE3 TLE4 KMT2A PRRC2B	4.59e-07	268	158	10	33640491
Pubmed	Mint represses transactivation of the type II collagen gene enhancer through interaction with alpha A-crystallin-binding protein 1.	HIVEP1 NCOR2 SPEN	9.14e-07	5	158	3	15778499
Pubmed	LIM-only protein Lmo2 forms a protein complex with erythroid transcription factor GATA-1.	TCF3 LDB1 TAL1	9.14e-07	5	158	3	9209374
Pubmed	SCL and associated proteins distinguish active from repressive GATA transcription factor complexes.	TCF3 LDB1 TAL1	9.14e-07	5	158	3	19011221
Pubmed	A stable transcription factor complex nucleated by oligomeric AML1-ETO controls leukaemogenesis.	TCF3 LDB1 LYL1	9.14e-07	5	158	3	23812588
Pubmed	A pentamer transcriptional complex including tal-1 and retinoblastoma protein downmodulates c-kit expression in normal erythroblasts.	TCF3 LDB1 TAL1	9.14e-07	5	158	3	10866689
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: III. the complete nucleotide sequences of 500 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	NUDCD3 BAHD1 TIAM2 STAB1 ST6GAL2 MAST4 COQ8A TNKS1BP1 CACNA1G IGSF1 PLXNB1 ZNF687 PPP6R3	1.00e-06	529	158	13	14621295
Pubmed	LSD1-mediated epigenetic modification is required for TAL1 function and hematopoiesis.	TCF3 LDB1 LYL1 TAL1	1.19e-06	18	158	4	19497860
Pubmed	Runx genes are direct targets of Scl/Tal1 in the yolk sac and fetal liver.	TCF3 LDB1 TAL1	3.18e-06	7	158	3	18184866
Pubmed	Eto2/MTG16 and MTGR1 are heteromeric corepressors of the TAL1/SCL transcription factor in murine erythroid progenitors.	TCF3 LDB1 TAL1	3.18e-06	7	158	3	19799863
Pubmed	Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability.	HIVEP1 OTUD5 APC NUDCD3 CNTLN ARID1A NCKAP5L NCOR2 TNKS1BP1 SPEN CEP170B PRRC2B PPP6R3	3.20e-06	588	158	13	38580884
Pubmed	A probability-based approach for high-throughput protein phosphorylation analysis and site localization.	APC IFI16 TLE3 PKP3 EIF5B TNKS1BP1 TACC3 SRRM2 SPEN PRRC2A ZNF687 PPP6R3	3.59e-06	503	158	12	16964243
Pubmed	Proximity-dependent biotin identification (BioID) reveals a dynamic LSD1-CoREST interactome during embryonic stem cell differentiation.	HIVEP1 PPFIA1 APC ZMIZ1 RLF NCOR2 TLE3 TLE4 TNKS1BP1 TACC3 ZNF687	3.67e-06	418	158	11	34709266
Pubmed	Proteome-scale mapping of binding sites in the unstructured regions of the human proteome.	TSPOAP1 DDN BCL9 NCOR2 ZNF469 PRR14 TNRC18 AATK TSHZ1 IGSF9B SPEN	4.80e-06	430	158	11	35044719
Pubmed	The Eyes Absent family members EYA4 and EYA1 promote PLK1 activation and successful mitosis through tyrosine dephosphorylation.	TCF3 ZMIZ1 BCL9 NCOR2 LDB1 FAM222B PRRC2B	6.51e-06	152	158	7	38360978
Pubmed	LIM-homeodomain proteins Lhx1 and Lhx5, and their cofactor Ldb1, control Purkinje cell differentiation in the developing cerebellum.	LHX1 LDB1 LHX5	7.57e-06	9	158	3	17664423
Pubmed	Spatiotemporal profile of postsynaptic interactomes integrates components of complex brain disorders.	VGF ZNF219 NRCAM PPFIA1 APC DDN CORO1B BCL9 NCOR2 KCNA3 LDB1 SIPA1L1 TACC3 PRRC2A CEP170B PRRC2B	8.87e-06	963	158	16	28671696
Pubmed	Identifications of novel host cell factors that interact with the receptor-binding domain of the SARS-CoV-2 spike protein.	EEFSEC APC GON4L MAP3K6 SLC4A2 LLGL1 COQ8A GORASP1 SLTM KMT2A YTHDF2 PLXNB1 PRRC2B	9.38e-06	650	158	13	38777146
Pubmed	Comprehensive identification of phosphorylation sites in postsynaptic density preparations.	SEPTIN4 MAPT SIPA1L1 SRRM2 PRRC2A CEP170B PRRC2B BRWD1	1.15e-05	231	158	8	16452087
Pubmed	An atlas of combinatorial transcriptional regulation in mouse and man.	ALX3 TCF3 ZNF219 APC POU3F4 GATA5 LHX1 NCOR2 ZBTB32 LDB1 EIF5B LHX5 SSBP4 SPEN TAL1	1.22e-05	877	158	15	20211142
Pubmed	Identification and functional characterization of transcriptional activators in human cells.	HIVEP1 APC GON4L ARID1A NCKAP5L NCOR2 TNRC18 TLE3 TSHZ1 BAHCC1	1.53e-05	398	158	10	35016035
Pubmed	Genetic and Proteomic Interrogation of Lower Confidence Candidate Genes Reveals Signaling Networks in β-Catenin-Active Cancers.	ZNF326 PSMB1 APC CORO1B ARID1A PAPSS1 AHDC1 SEC61A2 HOXA13 NCOR2 TNRC18 PKP3 SIPA1L1 EIF5B TNKS1BP1 SRRM2 PRRC2A PPP6R3	1.60e-05	1247	158	18	27684187
Pubmed	A census of human transcription factors: function, expression and evolution.	ALX3 TCF3 HIVEP1 GON4L POU3F4 GATA5 HOXA13 PITX1 KMT2A TSHZ1 LHX5 LYL1 TAL1 FOXF1 TBX5	1.83e-05	908	158	15	19274049
Pubmed	An inducible CRISPR/Cas9 screen identifies DTX2 as a transcriptional regulator of human telomerase.	TCF3 BCL9 NCOR2 LLGL1 LATS2 LDB1 PKP3	1.96e-05	180	158	7	35198878
Pubmed	Loss of Ptf1a Leads to a Widespread Cell-Fate Misspecification in the Brainstem, Affecting the Development of Somatosensory and Viscerosensory Nuclei.	MAPT LHX1 LHX5	1.96e-05	12	158	3	26937009
Pubmed	Dynamic spatiotemporal expression of LIM genes and cofactors in the embryonic and postnatal cerebral cortex.	LHX1 LDB1 LHX5	1.96e-05	12	158	3	12619132
Pubmed	LMO4 controls the balance between excitatory and inhibitory spinal V2 interneurons.	TCF3 LDB1 TAL1	1.96e-05	12	158	3	19323994
Pubmed	Tbx4 function during hindlimb development reveals a mechanism that explains the origins of proximal limb defects.	HOXA13 PITX1 TBX5	1.96e-05	12	158	3	34423345
Pubmed	Expression of Dlx and Lhx family homeobox genes in fetal thymus and thymocytes.	LHX1 LDB1 LHX5	1.96e-05	12	158	3	15053981
Pubmed	Hyperactive behaviour in the mouse model of mucopolysaccharidosis IIIB in the open field and home cage environments.	NAGLU PGF	2.05e-05	2	158	2	21635693
Pubmed	The LIM-homeodomain gene family in the developing Xenopus brain: conservation and divergences with the mouse related to the evolution of the forebrain.	LHX1 LHX5	2.05e-05	2	158	2	11567052
Pubmed	Adult hematopoietic stem and progenitor cells require either Lyl1 or Scl for survival.	LYL1 TAL1	2.05e-05	2	158	2	19200805
Pubmed	The paralogous hematopoietic regulators Lyl1 and Scl are coregulated by Ets and GATA factors, but Lyl1 cannot rescue the early Scl-/- phenotype.	LYL1 TAL1	2.05e-05	2	158	2	17053063
Pubmed	Gro/TLE enables embryonic stem cell differentiation by repressing pluripotent gene expression.	TLE3 TLE4	2.05e-05	2	158	2	25446531
Pubmed	Extracellular mRNA transported to the nucleus exerts translation-independent function.	ZC3H12A ZC3H12D	2.05e-05	2	158	2	34135341
Pubmed	CircFAT1 regulates retinal pigment epithelial cell pyroptosis and autophagy via mediating m6A reader protein YTHDF2 expression in diabetic retinopathy.	FAT1 YTHDF2	2.05e-05	2	158	2	35714699
Pubmed	Conformational Selection Mechanism Provides Structural Insights into the Optimization of APC-Asef Inhibitors.	APC ARHGEF4	2.05e-05	2	158	2	33670371
Pubmed	Helix-loop-helix proteins LYL1 and E2a form heterodimeric complexes with distinctive DNA-binding properties in hematolymphoid cells.	TCF3 LYL1	2.05e-05	2	158	2	8628307
Pubmed	The Tal1 oncoprotein inhibits E47-mediated transcription. Mechanism of inhibition.	TCF3 TAL1	2.05e-05	2	158	2	9507011
Pubmed	Molecular Mechanisms of ZC3H12C/Reg-3 Biological Activity and Its Involvement in Psoriasis Pathology.	ZC3H12A ZC3H12C	2.05e-05	2	158	2	34298932
Pubmed	The DNA binding activity of TAL-1 is not required to induce leukemia/lymphoma in mice.	TCF3 TAL1	2.05e-05	2	158	2	11439353
Pubmed	ARID1A loss in adult hepatocytes activates β-catenin-mediated erythropoietin transcription.	APC ARID1A	2.05e-05	2	158	2	33084574
Pubmed	TLE3 and TLE4-coordinated colonic macrophage-CD4+ T cell crosstalk maintains intestinal immune homeostasis.	TLE3 TLE4	2.05e-05	2	158	2	36801171
Pubmed	Interactions between LIM domains and the LIM domain-binding protein Ldb1.	LHX1 LDB1	2.05e-05	2	158	2	9468533
Pubmed	Decoding hematopoietic specificity in the helix-loop-helix domain of the transcription factor SCL/Tal-1.	TCF3 TAL1	2.05e-05	2	158	2	15314159
Pubmed	lyl-1 and tal-1/scl, two genes encoding closely related bHLH transcription factors, display highly overlapping expression patterns during cardiovascular and hematopoietic ontogeny.	LYL1 TAL1	2.05e-05	2	158	2	17112790
Pubmed	Truncated Adenomatous Polyposis Coli Mutation Induces Asef-Activated Golgi Fragmentation.	APC ARHGEF4	2.05e-05	2	158	2	29866653
Pubmed	Structural basis for the recognition of Asef by adenomatous polyposis coli.	APC ARHGEF4	2.05e-05	2	158	2	21788986
Pubmed	Wnt signaling regulates the lineage differentiation potential of mouse embryonic stem cells through Tcf3 down-regulation.	TCF3 APC	2.05e-05	2	158	2	23658527
Pubmed	Delta-like 4/Notch signaling promotes Apc Min/+ tumor initiation through angiogenic and non-angiogenic related mechanisms.	DLL4 APC	2.05e-05	2	158	2	28086833
Pubmed	Targeting TRIM37-driven centrosome dysfunction in 17q23-amplified breast cancer.	NCKAP5L KIAA0753 NCOR2 C2CD3 SIPA1L1 SPEN CEP170B	2.25e-05	184	158	7	32908313
Pubmed	The RNA binding protein MEX3A promotes tumor progression of breast cancer by post-transcriptional regulation of IGFBP4.	COL5A2 ARID1A AHDC1 FAT1 TNRC18 TNKS1BP1 TACC3 PRRC2A PRRC2B	2.28e-05	332	158	9	37433992
Pubmed	The Midbrain Preisthmus: A Poorly Known Effect of the Isthmic Organizer.	NRCAM LHX1 PITX1 LHX5 TAL1	2.43e-05	75	158	5	37298722
Pubmed	Differential interactions of Id proteins with basic-helix-loop-helix transcription factors.	TCF3 LYL1 TAL1	2.54e-05	13	158	3	9242638
Pubmed	Genetic dissection of Gata2 selective functions during specification of V2 interneurons in the developing spinal cord.	DLL4 LHX1 LHX5	2.54e-05	13	158	3	25369423
Pubmed	Protein-protein interactions between large proteins: two-hybrid screening using a functionally classified library composed of long cDNAs.	NRCAM ZMIZ1 BAHD1 SIPA1L1 IGSF1 BAHCC1	3.00e-05	130	158	6	12421765
Pubmed	Origin of a Non-Clarke's Column Division of the Dorsal Spinocerebellar Tract and the Role of Caudal Proprioceptive Neurons in Motor Function.	MAPT LHX1 LHX5	3.23e-05	14	158	3	26527010
Pubmed	Identification of the SOX2 Interactome by BioID Reveals EP300 as a Mediator of SOX2-dependent Squamous Differentiation and Lung Squamous Cell Carcinoma Growth.	BCL9 ARID1A NCOR2 TLE3 SPEN	3.96e-05	83	158	5	28794006
Pubmed	Proteomic analysis of HIV-1 Gag interacting partners using proximity-dependent biotinylation.	PPFIA1 IFI16 EIF5B SRRM2	4.01e-05	42	158	4	26362536
Pubmed	Lbx1 acts as a selector gene in the fate determination of somatosensory and viscerosensory relay neurons in the hindbrain.	MAPT LHX1 LHX5	4.02e-05	15	158	3	17475798
Pubmed	Transcriptome characterization elucidates signaling networks that control human ES cell growth and differentiation.	CTAGE9 ZNF326 OTUD5 GON4L NUDCD3 BCL9 CCDC51 NCKAP5L AHDC1 NCOR2 ST6GAL2 FAT1 TNRC18 ZNHIT2 CEP170B PRRC2B PPP6R3	4.11e-05	1215	158	17	15146197
Pubmed	Transcriptome of the inner circular smooth muscle of the developing mouse intestine: Evidence for regulation of visceral smooth muscle genes by the hedgehog target gene, cJun.	TCF3 MAPT EMILIN3 TSHZ1 TAL1 FOXF1	4.54e-05	140	158	6	26930384
Pubmed	A differential developmental pattern of spinal interneuron apoptosis during synaptogenesis: insights from genetic analyses of the protocadherin-gamma gene cluster.	PCDHGB5 PCDHGB1 LHX1 LHX5	4.83e-05	44	158	4	19029045
Pubmed	Interactomes of Glycogen Synthase Kinase-3 Isoforms.	PPFIA1 APC MAST4 SIPA1L1 TNKS1BP1 CEP170B PPP6R3	5.07e-05	209	158	7	36779422
Pubmed	Sanfilippo syndrome type B, a lysosomal storage disease, is also a tauopathy.	MAPT NAGLU	6.13e-05	3	158	2	19416848
Pubmed	The transcriptional co-repressor TLE3 regulates myogenic differentiation by repressing the activity of the MyoD transcription factor.	TCF3 TLE3	6.13e-05	3	158	2	28607151
Pubmed	LMO2 is required for TAL1 DNA binding activity and initiation of definitive haematopoiesis at the haemangioblast stage.	LDB1 TAL1	6.13e-05	3	158	2	28973433
Pubmed	Hindlimb patterning and mandible development require the Ptx1 gene.	PITX1 TBX5	6.13e-05	3	158	2	10101115
Pubmed	Structural insights into the recruitment of SMRT by the corepressor SHARP under phosphorylative regulation.	NCOR2 SPEN	6.13e-05	3	158	2	24268649
Pubmed	The LIM-domain binding protein Ldb1 and its partner LMO2 act as negative regulators of erythroid differentiation.	LDB1 TAL1	6.13e-05	3	158	2	9391090
Pubmed	Plakophilin3 loss leads to increased adenoma formation and rectal prolapse in APCmin mice.	APC PKP3	6.13e-05	3	158	2	34823217
Pubmed	Similarities and differences in the forebrain expression of Lhx1 and Lhx5 between chicken and mouse: Insights for understanding telencephalic development and evolution.	LHX1 LHX5	6.13e-05	3	158	2	20589911
Pubmed	Divergent transcriptional activities determine limb identity.	PITX1 TBX5	6.13e-05	3	158	2	20975709
Pubmed	Interactions of the LIM-domain-binding factor Ldb1 with LIM homeodomain proteins.	LHX1 LDB1	6.13e-05	3	158	2	8918878
Pubmed	Cell fate determinant Llgl1 is required for propagation of acute myeloid leukemia.	LLGL1 KMT2A	6.13e-05	3	158	2	37587260
Pubmed	Identification of a TAL1 target gene reveals a positive role for the LIM domain-binding protein Ldb1 in erythroid gene expression and differentiation.	LDB1 TAL1	6.13e-05	3	158	2	14560005
Pubmed	Tbx5 and Tbx4 are not sufficient to determine limb-specific morphologies but have common roles in initiating limb outgrowth.	PITX1 TBX5	6.13e-05	3	158	2	15621531
Pubmed	Histone methyltransferase WHSC1 loss dampens MHC-I antigen presentation pathway to impair IFN-γ-stimulated antitumor immunity.	APC NLRC5	6.13e-05	3	158	2	35230972
Pubmed	Somatic Apc mutations are selected upon their capacity to inactivate the beta-catenin downregulating activity.	EEFSEC APC	6.13e-05	3	158	2	10992298
Pubmed	Identification and characterization of Asef2, a guanine-nucleotide exchange factor specific for Rac1 and Cdc42.	APC ARHGEF4	6.13e-05	3	158	2	17599059
Pubmed	Tle corepressors are differentially partitioned to instruct CD8+ T cell lineage choice and identity.	TLE3 TLE4	6.13e-05	3	158	2	30045946
Pubmed	The LIM-only protein Lmo2 is a bridging molecule assembling an erythroid, DNA-binding complex which includes the TAL1, E47, GATA-1 and Ldb1/NLI proteins.	TCF3 LDB1	6.13e-05	3	158	2	9214632
Pubmed	Formation of in vivo complexes between the TAL1 and E2A polypeptides of leukemic T cells.	TCF3 TAL1	6.13e-05	3	158	2	8159721
Interaction	TLE3 interactions	TCF3 HIVEP1 ZMIZ1 BCL9 ARID1A AHDC1 NCOR2 TNRC18 LDB1 TLE3 TLE4 KMT2A TNKS1BP1 SSBP4 SRRM2 SPEN	2.94e-08	376	153	16	int:TLE3
Interaction	TOP3B interactions	DPH2 NAGLU MYOM3 CORO1B BCL9 MBD6 ARID1A AHDC1 BAHD1 RNF43 TIAM2 NCOR2 TLK1 FAT1 TNRC18 C2CD3 AATK LATS2 ADAMTS7 PITX1 NLRC5 TNKS1BP1 ARHGEF4 SSBP4 SPEN PRRC2A YTHDF2 CEP170B PRRC2B ZNF687 RBM38 BAHCC1	4.86e-08	1470	153	32	int:TOP3B
Interaction	EGR2 interactions	HIVEP1 BCL9 ARID1A AHDC1 NCOR2 TNRC18 LDB1 TLE3 KMT2A PRRC2B BAHCC1	7.83e-08	171	153	11	int:EGR2
Interaction	TBR1 interactions	HIVEP1 ZMIZ1 BCL9 ARID1A NCOR2 LDB1 TLE3 TLE4 PITX1	2.02e-07	113	153	9	int:TBR1
Interaction	GSC interactions	HIVEP1 BCL9 NCOR2 TNRC18 LDB1 TLE3 TLE4 BAHCC1	3.23e-07	87	153	8	int:GSC
Interaction	NUP35 interactions	ZNF326 AUP1 ZMIZ1 BCL9 ARID1A IFI16 AHDC1 NCOR2 TLE3 PKP3 FAM222B ARHGEF4 YTHDF2 PRRC2B TBX5	8.62e-07	424	153	15	int:NUP35
Interaction	PAX8 interactions	HIVEP1 BCL9 ARID1A NCOR2 LDB1 TLE3 TLE4 PRRC2B	2.09e-06	111	153	8	int:PAX8
Interaction	LDB1 interactions	TCF3 BCL9 LHX1 LDB1 TLE3 LHX5 SSBP4 TAL1	2.73e-06	115	153	8	int:LDB1
Interaction	TBXT interactions	HIVEP1 BCL9 ARID1A NCOR2 LDB1 TLE3 TLE4 SPEN	2.92e-06	116	153	8	int:TBXT
Interaction	GATA2 interactions	HIVEP1 BCL9 ARID1A NCOR2 ZBTB32 LDB1 TLE3 TLE4 TAL1 PRRC2B	2.97e-06	199	153	10	int:GATA2
Interaction	FEV interactions	HIVEP1 BCL9 ARID1A RLF NCOR2 LDB1 TLE3 TLE4 KMT2A PRRC2B	3.54e-06	203	153	10	int:FEV
Interaction	CRX interactions	ZMIZ1 BCL9 ARID1A RLF NCOR2 TNRC18 LDB1 TLE3 SPEN PRRC2B BAHCC1	3.96e-06	254	153	11	int:CRX
Interaction	PAX7 interactions	HIVEP1 BCL9 ARID1A NCOR2 LDB1 TLE3 TLE4 SSBP4	4.81e-06	124	153	8	int:PAX7
Interaction	HDAC1 interactions	ZNF219 HIVEP1 PPFIA1 APC GON4L ZMIZ1 ARID1A BAHD1 RLF NCOR2 TNRC18 KCNA3 LATS2 TLE3 TLE4 KMT2A TNKS1BP1 TACC3 SPEN TAL1 ZNF687 PPP6R3 BAHCC1	1.07e-05	1108	153	23	int:HDAC1
Interaction	ALG13 interactions	BCL9 ARID1A RNF43 NCOR2 TLE3 PITX1 PRRC2A YTHDF2 PRRC2B	1.12e-05	183	153	9	int:ALG13
Interaction	GCM1 interactions	HIVEP1 BCL9 ARID1A NCOR2 TLE3 PRRC2B	1.29e-05	68	153	6	int:GCM1
Interaction	NFIB interactions	HIVEP1 BCL9 ARID1A RLF LHX1 NCOR2 LDB1 TLE3	1.31e-05	142	153	8	int:NFIB
Interaction	GATA3 interactions	HIVEP1 SEPTIN4 BCL9 ARID1A NCOR2 TLE3 TAL1 PRRC2B PPP6R3	1.33e-05	187	153	9	int:GATA3
Interaction	LHX1 interactions	HIVEP1 BCL9 ARID1A LHX1 NCOR2 LDB1 SSBP4	1.36e-05	103	153	7	int:LHX1
Interaction	SP7 interactions	HIVEP1 ZMIZ1 BCL9 ARID1A NCOR2 LDB1 TLE3 TLE4 PITX1 PRRC2B PPP6R3	2.15e-05	304	153	11	int:SP7
Interaction	LMO1 interactions	ZNF219 PSMB1 NUTM1 LDB1 SSBP4 LYL1 TAL1 MN1	2.35e-05	154	153	8	int:LMO1
Interaction	SOX2 interactions	TCF3 HIVEP1 PSMB1 CORO1B CNTLN BCL9 ARID1A AHDC1 RLF NCOR2 PRR14 TNRC18 C2CD3 LDB1 TLE3 PKP3 SIPA1L1 PITX1 SLTM EIF5B KMT2A SPEN YTHDF2 PRRC2B ZNF687 RBM38	2.48e-05	1422	153	26	int:SOX2
Interaction	KDM1A interactions	TCF3 HIVEP1 MAPT DBF4B PPFIA1 APC NUDCD3 ZMIZ1 BAHD1 RLF ZBP1 NCOR2 TLE3 TLE4 TNKS1BP1 TACC3 TAL1 ZNF687 PPP6R3 TBX5	3.06e-05	941	153	20	int:KDM1A
Interaction	SMG7 interactions	HIVEP1 BCL9 ARID1A RNF43 KIAA0753 NCOR2 TLE3 TLE4 PRRC2A YTHDF2 PRRC2B	3.34e-05	319	153	11	int:SMG7
Interaction	LHX4 interactions	HIVEP1 CORO1B BCL9 ARID1A NCOR2 LDB1 SSBP4 ZNF687	4.02e-05	166	153	8	int:LHX4
Interaction	IFNE interactions	VGF NAGLU FAT1 PCDH1	4.89e-05	27	153	4	int:IFNE
Interaction	GATA1 interactions	BCL9 ARID1A NCOR2 LDB1 TLE3 PITX1 TAL1 MGAT5B	4.97e-05	171	153	8	int:GATA1
Interaction	FMR1 interactions	ZNF219 MAPT APC BCL9 IFI16 ZBP1 NCOR2 AATK LDB1 TLE4 PRRC2A YTHDF2 CEP170B PRRC2B	6.08e-05	536	153	14	int:FMR1
Interaction	CTBP1 interactions	TCF3 ZNF219 MAPT APC NCKAP5L ZBP1 NCOR2 KMT2A TSHZ1 SRRM2 SPEN PRRC2B	6.52e-05	406	153	12	int:CTBP1
Interaction	LHX6 interactions	HIVEP1 BCL9 LDB1 TLE3 SSBP4	7.83e-05	58	153	5	int:LHX6
Interaction	LHX2 interactions	HIVEP1 BCL9 ARID1A NCOR2 TLK1 LDB1 SSBP4 ZNF687	8.00e-05	183	153	8	int:LHX2
Interaction	SSBP4 interactions	BCL9 LHX1 LDB1 TLE3 SSBP4	8.50e-05	59	153	5	int:SSBP4
Interaction	LHX3 interactions	HIVEP1 PSMB1 BCL9 ARID1A LHX1 NCOR2 LDB1 SSBP4	8.63e-05	185	153	8	int:LHX3
Interaction	MFAP4 interactions	NAGLU FUT11 LDB1 ADAMTS7 TLE3 TLE4 SSBP4	9.36e-05	139	153	7	int:MFAP4
Interaction	HNF1B interactions	HIVEP1 BCL9 MBD6 ARID1A NCOR2 LDB1 TLE3 PRRC2B	1.04e-04	190	153	8	int:HNF1B
Interaction	RCOR1 interactions	TCF3 HIVEP1 PPFIA1 APC NCKAP5L RLF NCOR2 TNKS1BP1 SPEN TAL1 ZNF687 PPP6R3 TBX5	1.04e-04	494	153	13	int:RCOR1
Interaction	SNRNP40 interactions	ZNF326 HIVEP1 GON4L NUDCD3 BCL9 ARID1A AHDC1 NCOR2 TLK1 PRDM10 USP42 KMT2A SRRM2 SPEN ZNHIT2	1.05e-04	637	153	15	int:SNRNP40
Interaction	LYL1 interactions	TCF3 LYL1 TAL1	1.16e-04	13	153	3	int:LYL1
Interaction	KLF5 interactions	HIVEP1 BCL9 ARID1A NCOR2 LDB1 TLE3 PRRC2A PRRC2B	1.24e-04	195	153	8	int:KLF5
Interaction	SSBP2 interactions	BCL9 IGLL5 LHX1 LDB1 SSBP4 TAL1	1.50e-04	105	153	6	int:SSBP2
Interaction	ATXN1L interactions	HIVEP1 MBD6 NCOR2 ZBTB32 TLE3 PRRC2A PRRC2B	1.51e-04	150	153	7	int:ATXN1L
Interaction	FBXO42 interactions	HIVEP1 APC NUDCD3 CNTLN ARID1A NCKAP5L NCOR2 TNKS1BP1 PRRC2B	1.66e-04	259	153	9	int:FBXO42
Interaction	CEBPA interactions	EEFSEC TCF3 HIVEP1 PSMB1 BCL9 ARID1A IFI16 AHDC1 RLF HOXA13 NCOR2 TLK1 TNRC18 TLE3 PITX1 EIF5B KMT2A SRRM2 SPEN PRRC2A PRRC2B ZNF687	1.83e-04	1245	153	22	int:CEBPA
Interaction	RUNX1 interactions	TCF3 ZNF326 ARID1A NCOR2 TLE3 FAM222B KMT2A SPEN TAL1 PRRC2A	1.90e-04	324	153	10	int:RUNX1
Interaction	AR interactions	ZNF326 HIVEP1 PSMB1 ZMIZ1 BCL9 ARID1A CCDC51 IFI16 AHDC1 HOXA13 NCOR2 TNRC18 ZBTB32 LATS2 LDB1 TLE3 TLE4 KMT2A PRRC2B	1.91e-04	992	153	19	int:AR
Interaction	EN1 interactions	HIVEP1 NCOR2 TLE3 TLE4 KMT2A SRRM2	1.94e-04	110	153	6	int:EN1
Interaction	IRF2BP2 interactions	TCF3 NCOR2 LDB1 TLE3 SPEN TAL1	1.94e-04	110	153	6	int:IRF2BP2
Interaction	CEP135 interactions	APC CNTLN NCKAP5L RNF43 KIAA0753 C2CD3 SIPA1L1 CEP170B PRRC2B	2.39e-04	272	153	9	int:CEP135
Interaction	ISL1 interactions	BCL9 LHX1 LDB1 SSBP4	2.60e-04	41	153	4	int:ISL1
Interaction	ISL2 interactions	BCL9 LHX1 LDB1 SSBP4	2.60e-04	41	153	4	int:ISL2
Interaction	AHSP interactions	ZC3H12A PSMB1 PKP3	2.70e-04	17	153	3	int:AHSP
Interaction	AURKA interactions	TCF3 ZNF326 OTUD5 PSMB1 IFI16 NCOR2 TLK1 KCNA3 LATS2 USP42 PITX1 TNKS1BP1 TACC3 FOXF1 PPP6R3	2.75e-04	696	153	15	int:AURKA
Interaction	CBFA2T3 interactions	TCF3 LDB1 SSBP4 LYL1 TAL1	3.19e-04	78	153	5	int:CBFA2T3
Interaction	ZC3H12D interactions	ZC3H12A ZC3H12D	3.40e-04	4	153	2	int:ZC3H12D
Interaction	NFIX interactions	HIVEP1 ARID1A RLF NCOR2 JMJD6 TLE3 KMT2A SPEN	3.50e-04	227	153	8	int:NFIX
Interaction	MAPRE3 interactions	MAPT PSMB1 APC NCKAP5 NCKAP5L MAST4 PRRC2A CEP170B	3.82e-04	230	153	8	int:MAPRE3
Interaction	TLX1 interactions	HIVEP1 BCL9 ARID1A NCOR2 LDB1 TLE3 TLE4	3.86e-04	175	153	7	int:TLX1
Interaction	TLX3 interactions	HIVEP1 BCL9 ARID1A NCOR2 ZBTB32 LDB1 TLE3 TLE4 PITX1	3.92e-04	291	153	9	int:TLX3
Interaction	CNOT9 interactions	APC NUDCD3 KIAA0753 AATK TNKS1BP1 PRRC2A YTHDF2 PRRC2B	3.93e-04	231	153	8	int:CNOT9
Interaction	SOX7 interactions	ARID1A NCOR2 TNRC18 TLE3 BAHCC1	4.03e-04	82	153	5	int:SOX7
Interaction	CBX3 interactions	MAPT IFI16 AHDC1 BAHD1 RLF PRR14 PRDM10 KCNA3 EIF5B KMT2A TNKS1BP1 SRRM2 SPEN PRRC2B	4.18e-04	646	153	14	int:CBX3
GeneFamily	Zinc fingers CCCH-type	ZC3H12A ZC3H12B ZC3H12D ZC3H12C	4.90e-05	35	105	4	73
Coexpression	GSE7348_UNSTIM_VS_TOLERIZED_AND_LPS_STIM_MACROPHAGE_UP	MBD6 SEC61A2 NCOR2 TLK1 LATS2 LYL1 YTHDF2 RABGGTB	6.27e-06	162	157	8	M6847
Coexpression	TERAMOTO_OPN_TARGETS_CLUSTER_8	NRCAM MAPT KIAA0753	1.15e-05	8	157	3	MM525
Coexpression	TERAMOTO_OPN_TARGETS_CLUSTER_8	NRCAM MAPT KIAA0753	1.15e-05	8	157	3	M1204
Coexpression	BENPORATH_SUZ12_TARGETS	ZMYND15 ALX3 DCHS2 NRCAM DLL4 MAPT POU3F4 GATA5 KCNA3 PITX1 GPR137B CACNA1G LHX5 LTBP2 TAL1 MGAT5B EPHA10 FOXF1 TBX5	1.48e-05	1035	157	19	M9898
Coexpression	BENPORATH_EED_TARGETS	ZMYND15 ALX3 VGF DCHS2 NRCAM DLL4 MAPT POU3F4 ARID1A HOXA13 KCNA3 PITX1 CACNA1G LHX5 LTBP2 SRRM2 TAL1 FOXF1 TBX5	2.03e-05	1059	157	19	M7617
Coexpression	GSE37533_PPARG1_FOXP3_VS_PPARG2_FOXP3_TRANSDUCED_CD4_TCELL_PIOGLITAZONE_TREATED_UP	PLPPR3 ZMIZ1 CDC42EP3 TIAM2 LHX5 LYL1 MN1 RBM38	2.50e-05	196	157	8	M8970
Coexpression	GSE13484_UNSTIM_VS_3H_YF17D_VACCINE_STIM_PBMC_UP	TCF3 NAGLU NUDCD3 C2CD3 COQ8A DPEP2 SPEN TBX5	2.79e-05	199	157	8	M3257
Coexpression	BENPORATH_PRC2_TARGETS	ZMYND15 ALX3 DCHS2 DLL4 MAPT POU3F4 KCNA3 PITX1 CACNA1G LHX5 LTBP2 TAL1 FOXF1 TBX5	3.89e-05	650	157	14	M8448
Coexpression	PETROVA_ENDOTHELIUM_LYMPHATIC_VS_BLOOD_DN	NRCAM CDC42EP3 PGF LTBP2 LYL1 PCDH1 CEP170B	5.67e-05	162	157	7	M1459
ToppCell	Tracheal-10x3prime_v2-Stromal-Fibroblastic-Fibro_myofibroblast\|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations	ALX3 COL5A2 NRCAM SEPTIN4 POU3F4 GATA5 PRR16 LTBP2 TBX5	3.93e-08	198	158	9	08d393853e195a7eacace454153e425a273e2d23
ToppCell	wk_20-22-Mesenchymal-Myofibro_&_SMC\|wk_20-22 / Celltypes from embryonic and fetal-stage human lung	NRCAM SEPTIN4 MAPT FAT1 LTBP2 IGSF1 FOXF1 TBX5	5.81e-07	199	158	8	aacd3ffa40a6e6f435aa9be5b959d88812eb69d4
ToppCell	wk_15-18-Mesenchymal-Myofibro_&_SMC-Myofibro_2\|wk_15-18 / Celltypes from embryonic and fetal-stage human lung	RNF43 FAT1 LTBP2 IGSF1 CNGB1 FOXF1 TBX5	1.51e-06	157	158	7	b9d04ee417c0d8ea0801d10f1c54e138587009fd
ToppCell	Children_(3_yrs)-Mesenchymal-airway_smooth_muscle_cell-D046\|Children_(3_yrs) / Lineage, Cell type, age group and donor	COL5A2 NRCAM GATA5 PRR16 LTBP2 IGSF9B TBX5	2.02e-06	164	158	7	e3983f655cdba308fb192182829f17bef99ce0ba
ToppCell	facs-Trachea-24m-Hematologic-lymphocytic-B_cell\|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	ACAP1 TCF3 ZBTB32 COQ8A SIPA1L1 ZC3H12D RBM38	3.23e-06	176	158	7	318dc722b95e269002fb01a0feb91c0c8539e150
ToppCell	facs-Trachea-24m-Hematologic-lymphocytic-B_cell-B_cell_of_the_trachea\|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	ACAP1 TCF3 ZBTB32 COQ8A SIPA1L1 ZC3H12D RBM38	3.23e-06	176	158	7	f6891006d816309edabe75b2abf60675f2958e55
ToppCell	Frontal_cortex-Endothelial-ENDOTHELIAL_STALK-Flt1_1-Endothelial_Stalk.Flt1.Gkn3_(Gkn3)\|Frontal_cortex / BrainAtlas - Mouse McCarroll V32	DLL4 CHRND PKP3 CNGB1 MAJIN	3.49e-06	65	158	5	c736a773a1b9cb16b51849a3bf0ccd9aeec7b342
ToppCell	Frontal_cortex-Endothelial-ENDOTHELIAL_STALK-Flt1_1-Endothelial_Stalk.Flt1.Gkn3_(Gkn3)-\|Frontal_cortex / BrainAtlas - Mouse McCarroll V32	DLL4 CHRND PKP3 CNGB1 MAJIN	3.49e-06	65	158	5	8f7eac868f1605830cc97d9d1676f3ebff47d49b
ToppCell	Frontal_cortex-Endothelial-ENDOTHELIAL_STALK-Flt1_1-Endothelial_Stalk.Flt1.Gkn3_(Gkn3)--\|Frontal_cortex / BrainAtlas - Mouse McCarroll V32	DLL4 CHRND PKP3 CNGB1 MAJIN	3.49e-06	65	158	5	350f33bcc5924d7e3c3318391d33a984763fe206
ToppCell	wk_20-22-Mesenchymal-Myofibro_&_SMC-Myofibro_3\|wk_20-22 / Celltypes from embryonic and fetal-stage human lung	NRCAM GATA5 FAT1 IGSF1 FOXF1 GOLGA6L7 TBX5	4.17e-06	183	158	7	f4ea7113ce9099222743d9ff02388d3d8a9e987b
ToppCell	PCW_10-12-Mesenchymal-Mesenchymal_myocytic-mes_immature_ASM2_(12)\|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung	NRCAM PLPPR3 RNF43 LTBP2 IGSF1 FOXF1 TBX5	4.81e-06	187	158	7	387cb27c8a20031cd87381a9e1172f1f62e1488b
ToppCell	H1299-infected\|H1299 / Cell line, Condition and Strain	AUP1 SLTM EIF5B KMT2A TACC3 SRRM2 PRRC2B	5.72e-06	192	158	7	9cf8049bdc3e0f81ce69042beac72b08d8f38b4e
ToppCell	wk_20-22-Mesenchymal-Myofibro_&_SMC-Myofibro_2\|wk_20-22 / Celltypes from embryonic and fetal-stage human lung	NRCAM FAT1 ADAMTS7 LTBP2 IGSF1 FOXF1 TBX5	5.92e-06	193	158	7	2f203f6f0c2135acb046c9351a633c3b5b254a46
ToppCell	PCW_10-12-Mesenchymal-Mesenchymal_myocytic\|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung	NRCAM PLPPR3 FAT1 LTBP2 IGSF1 FOXF1 TBX5	6.12e-06	194	158	7	67f5e2f05a8de2213ab80d5ea16fdee121684633
ToppCell	Bronchial-NucSeq-Stromal-Fibroblastic-Fibro_myofibroblast\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	COL5A2 NRCAM PGF PRR16 ADAMTS7 LTBP2 TBX5	6.33e-06	195	158	7	f5e91ce20a7ce528dc4c1a968c7bf096bf45c528
ToppCell	Brain_organoid-organoid_Paulsen_bioRxiv-1_mon-Proliferating-Cycling_Progenitors\|1_mon / Sample Type, Dataset, Time_group, and Cell type.	CNTLN ARID1A ST6GAL2 FAT1 USP42 KMT2A MN1	7.23e-06	199	158	7	358c4b3037f59378db8916a2fbe9ed4830cf1449
ToppCell	(08)_PNEC-(4)_1wkpi\|(08)_PNEC / shred by cell type and Timepoint	ZMIZ1 IGSF1 RBM38	9.13e-06	12	158	3	f1b105bcdbe03be6765c820b42c752a24d502212
ToppCell	TCGA-Brain-Primary_Tumor-Low_Grade_Glioma-Astrocytoma\|TCGA-Brain / Sample_Type by Project: Shred V9	ZNF326 ARID1A LYL1 SPEN TAL1 PLXNB1	2.48e-05	162	158	6	810881210e015c788814e4fe8d7a24c929cf2621
ToppCell	3'_v3-GI_small-bowel-Mast-Mast_cell_granulo-myelo\|GI_small-bowel / Manually curated celltypes from each tissue	CNTLN TIAM2 ADAMTS7 CACNA1G LYL1 TAL1	3.47e-05	172	158	6	3df11aefc09762fd1f94441324551178e030b249
ToppCell	Adult-Mesenchymal-pericyte_cell-D231\|Adult / Lineage, Cell type, age group and donor	COL5A2 NRCAM SEPTIN4 EMILIN3 CHRND TBX5	3.47e-05	172	158	6	858cee96c1c06160863b4adcd7023c0d678bd50f
ToppCell	Children_(3_yrs)-Mesenchymal-myofibroblast_cell-D046\|Children_(3_yrs) / Lineage, Cell type, age group and donor	COL5A2 NRCAM GATA5 PRR16 LTBP2 TBX5	3.59e-05	173	158	6	1f16d47f5548e257e4b17f8070c5619780a9c5fd
ToppCell	356C-Fibroblasts-Fibroblast-B_(Myofibroblast)\|356C / Donor, Lineage, Cell class and subclass (all cells)	COL5A2 ZC3H12B LTBP2 MGAT5B FOXF1 TBX5	3.59e-05	173	158	6	75e26a65071b0d2f30ed0b2aa9859c488f5cf362
ToppCell	356C-Fibroblasts-Fibroblast-B_(Myofibroblast)-\|356C / Donor, Lineage, Cell class and subclass (all cells)	COL5A2 ZC3H12B LTBP2 MGAT5B FOXF1 TBX5	3.59e-05	173	158	6	26e2e674f5d312fa8f61c11b553dc6101f063b16
ToppCell	NS-moderate-d_16-33-Lymphoid-B_cell\|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	IGLL5 ZBTB32 ZC3H12D LYL1 RBM38 PARP15	4.08e-05	177	158	6	320fd77c7c98e9305dcc34a168ec9d674539ed65
ToppCell	Children_(3_yrs)-Mesenchymal-pericyte_cell-D046\|Children_(3_yrs) / Lineage, Cell type, age group and donor	COL5A2 NRCAM NCKAP5 PRR16 LTBP2 TBX5	4.21e-05	178	158	6	185b44700f06ec58b3c09c80520502166c965fd6
ToppCell	5'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	COL5A2 POU3F4 GATA5 PRR16 LTBP2 TBX5	4.62e-05	181	158	6	9c157de9d3403e092c907599f2a2c16db5b21131
ToppCell	5'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast-Myofibroblasts\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	COL5A2 POU3F4 GATA5 PRR16 LTBP2 TBX5	4.62e-05	181	158	6	eea943fdcbef0bbaa8578f3296923e874893b405
ToppCell	3'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_B-B_cell-B_cells-B_cells_L.1.5.0.1\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	ACAP1 HIVEP1 RLF ZBTB32 RBM38 PARP15	4.62e-05	181	158	6	d66838fca0429cad2079cd8d92a5cd33eb0d3522
ToppCell	5'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast-Myofibroblasts-Myofibroblasts_L.2.3.2.0\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	COL5A2 POU3F4 GATA5 PRR16 LTBP2 TBX5	4.91e-05	183	158	6	bc7dd6a40ec9c773d005c1a46f305d40cdd0a326
ToppCell	Mild/Remission-B_intermediate-6\|World / disease group and sub_cluster of B and Plasma cells(res = 0.5)	CDC42EP3 ZBTB32 GPR137B PRRT1B SSBP4 PARP15	5.06e-05	184	158	6	3d4864605c812862cf8926e02370eea3b8ccf32f
ToppCell	wk_08-11-Hematologic_Lymphocytic-B-Immature_B\|wk_08-11 / Celltypes from embryonic and fetal-stage human lung	ACAP1 IGLL5 ZBP1 DPEP2 LYL1 PARP15	5.06e-05	184	158	6	e6669a1b7ea7e4f8e094add5117689470019d85d
ToppCell	3'-Broncho-tracheal-Immune_Lymphocytic-Lymphocytic_B-B_cell-B_cells-B_cells_L.1.5.0.1\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	ACAP1 HIVEP1 TIAM2 RLF RBM38 PARP15	5.21e-05	185	158	6	e913c64f9b4873443d88dce270f0b7b6d1b4cbce
ToppCell	368C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_3\|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)	MAPT TNRC18 LLGL1 USP42 GORASP1 GPR137B	5.21e-05	185	158	6	daea170d827226dda6750bf1838ffd82f070c4d4
ToppCell	3'-Broncho-tracheal-Immune_Lymphocytic-Lymphocytic_B-B_cell-B_cells\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	ACAP1 HIVEP1 TIAM2 RLF RBM38 PARP15	5.37e-05	186	158	6	1a1e5d85a5ad90afee234c12a9b54a5e93a8a2f2
ToppCell	3'-Broncho-tracheal-Immune_Lymphocytic-Lymphocytic_B-B_cell\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	ACAP1 HIVEP1 TIAM2 RLF RBM38 PARP15	5.37e-05	186	158	6	f1366638edaecad5cad6367440f4c693513bed7e
ToppCell	moderate-Lymphoid-B_cell\|moderate / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls	ACAP1 TCF3 IGLL5 ZBTB32 ZC3H12D PARP15	5.37e-05	186	158	6	fd2c4c3e8929ca5d64f6c5064e5f3d3d6ba07b5f
ToppCell	10x5'-Lung-Mast\|Lung / Manually curated celltypes from each tissue	NRCAM FAT1 ZBTB32 MAST4 ADAMTS7 TAL1	5.53e-05	187	158	6	f8ac5ca5cbe9c6f3d8c0fffc20fe08ca1aea43c0
ToppCell	10x5'-Lung-Mast-Mast_cells\|Lung / Manually curated celltypes from each tissue	NRCAM FAT1 ZBTB32 MAST4 ADAMTS7 TAL1	5.53e-05	187	158	6	da275d2c774b3e6a8ed77f777dd0676ecf2ddd2c
ToppCell	PCW_07-8.5-Endothelial-Endothelial_mature-endo_capillary_(2)\|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung	DLL4 DPEP2 IGSF9B LYL1 TAL1 PCDH1	5.53e-05	187	158	6	106f50ad85a92403037214f0e94702230284837f
ToppCell	Smart-seq2-spleen_(Smart-seq2)\|Smart-seq2 / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	ACAP1 ZC3H12A TSPOAP1 IGLL5 RBM38 PARP15	5.87e-05	189	158	6	b0244a9d1b5c8ad4708750b691184f3491b13900
ToppCell	PCW_13-14-Mesenchymal-Mesenchymal_myocytic-mes_immature_ASM2_(12)\|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung	NRCAM RNF43 LTBP2 IGSF1 FOXF1 TBX5	5.87e-05	189	158	6	0abc7a4900cc9033bc1be69b770ccc54a6bf41b4
ToppCell	wk_15-18-Mesenchymal-Myofibro_&_SMC-Myofibro_1\|wk_15-18 / Celltypes from embryonic and fetal-stage human lung	NRCAM RNF43 LTBP2 IGSF1 FOXF1 TBX5	6.04e-05	190	158	6	d24af6af3271e34afab744352afd28be8a7cc5c3
ToppCell	Mesenchymal-airway_smooth_muscle_cell\|World / Lineage, Cell type, age group and donor	NRCAM GATA5 FAT1 LTBP2 FOXF1 TBX5	6.04e-05	190	158	6	645e56b02edc3702c7db917b8ecd5eed0decaf71
ToppCell	COPD-Myeloid-Mast\|Myeloid / Disease state, Lineage and Cell class	NRCAM CDC42EP3 ZBTB32 MAST4 ADAMTS7 TAL1	6.04e-05	190	158	6	379dbac19110b76079a7a53209569e060a852acb
ToppCell	tumor_Lung-Myeloid_cells-CD207+CD1a+_LCs\|Myeloid_cells / Location, Cell class and cell subclass	ALX3 ACAP1 NRCAM PHETA1 CHRND CACNA1G	6.04e-05	190	158	6	58a6ab70737d719ca9725ac087f20dfe9be0463e
ToppCell	Control-B_intermediate-14\|Control / disease group and sub_cluster of B and Plasma cells(res = 0.5)	CORO1B ZBP1 ZBTB32 NLRC5 SSBP4 GOLGA6L7	6.22e-05	191	158	6	076302fd247aab6c0b187ac9e0c67a3ba46414ba
ToppCell	Fetal_29-31_weeks-Mesenchymal-myofibroblast_cell-D150\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	NRCAM CNTLN FAT1 LTBP2 FOXF1 TBX5	6.40e-05	192	158	6	72881b280a415e65f87a80ca1369cbb0b722a0c4
ToppCell	human_hepatoblastoma-Endothelial_cells\|human_hepatoblastoma / Sample and Cell Type and Tumor Cluster (all cells)	DLL4 CDC42EP3 PGF MAST4 NLRC5 TAL1	6.40e-05	192	158	6	e09f609fed033a25baacaf4a07bbbae1076da366
ToppCell	3'-Pediatric_IBD-SmallIntestine-Hematopoietic-T_cells-Treg\|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract	ACAP1 CORO1B TLK1 ZBTB32 MAST4 ZC3H12D	6.40e-05	192	158	6	b7e08cadb50f66c2efdde45e0fa8bab29367269b
ToppCell	PCW_13-14-Mesenchymal-Mesenchymal_myocytic\|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung	NRCAM FAT1 LTBP2 IGSF1 FOXF1 TBX5	6.59e-05	193	158	6	000b9e6a819b94ea2e6e9173daf97ba9ac2b6cc6
ToppCell	3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	COL5A2 NRCAM GATA5 PRR16 LTBP2 TBX5	6.78e-05	194	158	6	8fae8061b350336299aa81f378e07deadbd55123
ToppCell	5'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-pericyte_cell-Pericytes\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	COL5A2 NRCAM SEPTIN4 PRR16 FOXF1 TBX5	6.78e-05	194	158	6	8f19e553f18c313c2a2ff9453884b9484b255d71
ToppCell	nucseq-Mesenchymal-Myocytic\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	COL5A2 NRCAM PRR16 FAT1 LTBP2 TBX5	6.78e-05	194	158	6	2d66091097e106c7bee22e5281f50724700bdf8d
ToppCell	5'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-pericyte_cell\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	COL5A2 NRCAM SEPTIN4 PRR16 FOXF1 TBX5	6.78e-05	194	158	6	67fbb81b7d20cb63be27b2a2beea5b5689f8e08c
ToppCell	5'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-pericyte_cell-Pericytes-Pericytes_L.2.3.1.0\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	COL5A2 NRCAM SEPTIN4 PRR16 FOXF1 TBX5	6.78e-05	194	158	6	f95935153bd2c4c3c7b2b729da6f7e98b45fed79
ToppCell	3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast-Myofibroblasts\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	COL5A2 NRCAM GATA5 PRR16 LTBP2 TBX5	6.78e-05	194	158	6	4d7d24390fdb379f943ddcc70a63f23955e10163
ToppCell	Tracheal-10x5prime-Immune_Lymphocytic-T-T_CD4-T_reg\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	ACAP1 ZBP1 ZBTB32 KCNA3 ZC3H12D IGSF9B	7.18e-05	196	158	6	c0028307cf5dddfc4b5db1445fa83b74019a20bd
ToppCell	H1299-infected-SARSCoV2\|infected / Cell line, Condition and Strain	CNTLN SLTM EIF5B SSBP4 SRRM2 PRRC2A	7.38e-05	197	158	6	0fa3e4cf93e77d78b1f97b906c5b13ca741ae17e
ToppCell	Tracheal-NucSeq-Stromal-Myofibroblastic-Muscle_smooth_pulmonary\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	NRCAM GATA5 PRR16 IGSF9B MN1 TBX5	7.38e-05	197	158	6	ac4f53acb2f8a428b0f2fab3c30a34e095a1bed7
ToppCell	Control-B_intermediate-0\|Control / disease group and sub_cluster of B and Plasma cells(res = 0.5)	CORO1B TLK1 TLE3 NLRC5 SSBP4 PARP15	7.59e-05	198	158	6	97e66b845053201247e2241739328cd73f33975c
ToppCell	3'-Adult-LargeIntestine-Mesenchymal-fibroblastic-Stromal_1_(CCL11+)\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	COL5A2 SEPTIN4 PRR16 PITX1 GPR137B FOXF1	7.59e-05	198	158	6	38b37daf41d84e5bf913eb3f72963418b7c0aac6
ToppCell	Smart-start-Cell-Wel_seq-Non-neoplastic-Lymphoid-Plasma_B\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	CTAGE9 IGLL5 CHRND ZBP1 KCNA3 PKP3	7.59e-05	198	158	6	96236fa22545f6f4ff3aa8dc002963db8a3468ce
ToppCell	Tracheal-NucSeq-Stromal-Myofibroblastic-Muscle_smooth_airway_ASM\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	NRCAM GATA5 ST6GAL2 IGSF9B FOXF1 TBX5	7.59e-05	198	158	6	22e766df1276c5b14aa0d83f434f47140ebb98ea
ToppCell	Smart-start-Cell-Wel_seq-Non-neoplastic-Lymphoid-Plasma_B-Plasma_B-G\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	CTAGE9 IGLL5 CHRND ZBP1 KCNA3 PKP3	7.59e-05	198	158	6	9e0fdd63069d17430cdc25bf4ffc762afd5e1728
ToppCell	Smart-start-Cell-Wel_seq-Non-neoplastic-Lymphoid-Plasma_B-Plasma_B\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	CTAGE9 IGLL5 CHRND ZBP1 KCNA3 PKP3	7.59e-05	198	158	6	7eb521af938c2609a85d27e2aa7d4317ad6e1e44
ToppCell	Endothelial_cells-Endothelial-A\|Endothelial_cells / lung cells shred on cell class, cell subclass, sample id	IFI16 MAP3K6 CDC42EP3 MAST4 PCDH1 FOXF1	7.80e-05	199	158	6	2a1424c61ddcd1fea9574f7a3ad1955387458130
ToppCell	LPS_anti-TNF-Mesenchymal_myocytic-Myofibroblastic-MatrixFB_->_Myofibroblast\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	CNTLN PRR16 FAT1 TSHZ1 LTBP2 TBX5	7.80e-05	199	158	6	38cfd367ee8c074c11ba54edeb7a001e375e2687
ToppCell	LPS_IL1RA-Mesenchymal_myocytic-Myofibroblastic-MatrixFB_->_Myofibroblast\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	TIAM2 PRR16 FAT1 TSHZ1 LTBP2 TBX5	7.80e-05	199	158	6	6b3a0e5d52a30d0eed30e6a670f5b53bc233f70c
ToppCell	LPS_IL1RA-Endothelial-Endothelial-Gen_Cap\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	DLL4 NCKAP5 IFI16 MAST4 KMT2A BRWD1	8.02e-05	200	158	6	dccec522ab0d7fff62ad6273b02aa9022dbbb8eb
ToppCell	Bronchial-10x5prime-Stromal-Pericyte-Muscle_pericyte_pulmonary\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	COL5A2 NRCAM SEPTIN4 PRR16 FAT1 TBX5	8.02e-05	200	158	6	12326cc6f0af24bacba9493dc79e7c7347db2f41
ToppCell	Parenchyma_Control_(B.)-Stromal-TX-Smooth_muscle-1\|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type	NRCAM NCKAP5 FAT1 PCDH1 FOXF1 TBX5	8.02e-05	200	158	6	0c648941447c738caf62f2d71e296d6cca492c8b
ToppCell	Tracheal-10x5prime-Immune_Myeloid-Mast_cell\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	NRCAM CDC42EP3 STAB1 ZBTB32 ADAMTS7 LYL1	8.02e-05	200	158	6	c3511607692e05f44538a376253673dd18f77908
ToppCell	Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Smooth_muscle-1-\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	NRCAM NCKAP5 FAT1 PCDH1 FOXF1 TBX5	8.02e-05	200	158	6	522a51a284d2992d519c4669e1a48c8ebcc08c80
ToppCell	Parenchymal-10x3prime_v2-Immune_Myeloid-Myeloid-Megakaryocyte\|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations	MBD6 CDC42EP3 STAB1 USP42 KMT2A RBM38	8.02e-05	200	158	6	0d76b006d8e8b32174e65e400acd0674354b962c
ToppCell	LPS_only-Mesenchymal_myocytic-Myofibroblastic-MatrixFB_->_Myofibroblast\|LPS_only / Treatment groups by lineage, cell group, cell type	PRR16 FAT1 TSHZ1 LTBP2 IGSF9B TBX5	8.02e-05	200	158	6	a9ff3210127000b3dd9e97136163c98c2b0817d7
ToppCell	Bronchial-10x5prime-Stromal-Pericyte\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	COL5A2 NRCAM SEPTIN4 PRR16 FAT1 TBX5	8.02e-05	200	158	6	362706445edb33b313684efe50b1f44f5f816e67
ToppCell	Parenchymal-10x3prime_v2-Immune_Myeloid-Myeloid\|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations	MBD6 CDC42EP3 STAB1 USP42 KMT2A RBM38	8.02e-05	200	158	6	cc8368665bc6bb7c4f39632ccff07ceaa98a7b65
ToppCell	Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Smooth_muscle-1\|Control / Location, Disease Group, Cell group, Cell class (2021.03.09)	NRCAM NCKAP5 FAT1 PCDH1 FOXF1 TBX5	8.02e-05	200	158	6	94f1fa61aa82eb9f411b2b1cb759476939ab5db7
ToppCell	Parenchymal-10x5prime-Stromal-Pericyte-Muscle_pericyte_pulmonary\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	COL5A2 NRCAM SEPTIN4 PRR16 FAT1 TBX5	8.02e-05	200	158	6	f9bc22ff17bb1c751e6b05bca3f403836f33459a
ToppCell	Tracheal-10x5prime-Immune_Myeloid-Mast_cell-Mast_cell\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	NRCAM CDC42EP3 STAB1 ZBTB32 ADAMTS7 LYL1	8.02e-05	200	158	6	1c58860932ed47263a5a537a64f0343201463c21
ToppCell	Parenchymal-10x5prime-Stromal-Pericyte\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	COL5A2 NRCAM SEPTIN4 PRR16 FAT1 TBX5	8.02e-05	200	158	6	0a7640db28c708003d5da2d19eb651f6fedfd710
ToppCell	PND01-03-samps-Lymphocyte-B_cell-B_cell_1\|PND01-03-samps / Age Group, Lineage, Cell class and subclass	ZBTB32 ZC3H12D NLRC5 RBM38 MAJIN	9.37e-05	128	158	5	5d82247ceda55017628720ed8b6c36ff7cec8437
ToppCell	LPS-antiTNF-Epithelial_alveolar-Mes-Like-Differentiating_AT1\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ZC3H12B TIAM2 ST6GAL2 LONRF2 ZNF687	9.37e-05	128	158	5	2cf0384240a4a663869cf6b27d954236f6214a9a
ToppCell	PND01-03-samps-Lymphocyte\|PND01-03-samps / Age Group, Lineage, Cell class and subclass	ZBTB32 ZC3H12D NLRC5 RBM38 MAJIN	9.37e-05	128	158	5	d3158825a2178244b57ac5ad2676617fd58d8466
ToppCell	PND01-03-samps-Lymphocyte-B_cell\|PND01-03-samps / Age Group, Lineage, Cell class and subclass	ZBTB32 ZC3H12D NLRC5 RBM38 MAJIN	9.37e-05	128	158	5	7661402dd7cd533c1bfe8d9247cecd88c1be9a5e
ToppCell	Tracheal-NucSeq-Immune_Myeloid-Dendritic_cell-DC_plasmacytoid\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	ZMYND15 DPH2 STAB1 LYL1	1.32e-04	73	158	4	582faedb369a099d0acf1565413e6b3ca2cfc564
ToppCell	TCGA-Uterus\|World / Sample_Type by Project: Shred V9	ALX3 EMILIN3 CHRND ADAMTS7 CACNA1G	1.63e-04	144	158	5	7efb45286ebf2dbfb9125fd6373f28dccb029a2e
ToppCell	Severe-Myeloid-Mast-\|Severe / Condition, Lineage, Cell class and cell subclass	NRCAM PCDHGB5 ZC3H12B ADAMTS7 TAL1	1.68e-04	145	158	5	ce307d45425a5191882078f049f85477eec40b69
ToppCell	Severe-Myeloid-Mast\|Severe / Condition, Lineage, Cell class and cell subclass	NRCAM PCDHGB5 ZC3H12B ADAMTS7 TAL1	1.68e-04	145	158	5	e0bfd2ffdbd6c197ef0a04e983396ebd87ef7127
ToppCell	368C-Lymphocytic-CD4_T-cell-Treg_cell_1\|368C / Donor, Lineage, Cell class and subclass (all cells)	ACAP1 BAHD1 MAST4 ZC3H12D RBM38	1.85e-04	148	158	5	80470353e12599440f711b6e107730763376d04d
Drug	Lactobionic acid [96-82-2]; Up 200; 11.2uM; PC3; HT_HG-U133A	PSMB1 DDN STAB1 LHX1 LLGL1 MAST4 DPEP2 TLE4 SRRM2 PLXNB1	1.04e-06	197	155	10	6605_UP
Drug	Corticosterone [50-22-6]; Down 200; 11.6uM; PC3; HT_HG-U133A	VGF ZNF219 MAPT PSMB1 NUDCD3 SEC61A2 NCOR2 PKP3 TLE4 PITX1	1.13e-06	199	155	10	4064_DN
Drug	Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HG-U133A	ARID1A CCDC51 TLK1 PRDM10 LDB1 KMT5B SIPA1L1 SRRM2 PRRC2A	4.51e-06	182	155	9	1951_DN
Drug	novobiocin sodium, USP; Down 200; 100uM; SKMEL5; HG-U133A	TCF3 GON4L BAHD1 PRR14 LDB1 COQ8A TLE3 PRRC2A PRRC2B	7.90e-06	195	155	9	632_DN
Drug	Pyrantel tartrate [33401-94-4]; Up 200; 11.2uM; PC3; HT_HG-U133A	SEPTIN4 MAPT APC DDN BCL9 AHDC1 MAST4 PKP3 LYL1	8.23e-06	196	155	9	2097_UP
Drug	Levonordefrin [829-74-3]; Down 200; 21.8uM; MCF7; HT_HG-U133A	TCF3 RTL10 BCL9 KIAA0753 MAST4 LDB1 SIPA1L1 EIF5B SRRM2	8.57e-06	197	155	9	7208_DN
Drug	(-)-Cinchonidine [485-71-2]; Down 200; 13.6uM; MCF7; HT_HG-U133A	VGF DPH2 APC AHDC1 LDB1 TLE3 ZNHIT2 PLXNB1 PPP6R3	8.93e-06	198	155	9	7190_DN
Drug	Trifluridine [70-00-8]; Up 200; 13.6uM; HL60; HT_HG-U133A	ZNF219 NRCAM SEPTIN4 IGLL5 STAB1 PRDM10 CACNA1G LTBP2 CNGB1	9.30e-06	199	155	9	6136_UP
Drug	Gemfibrozil [25812-30-0]; Down 200; 16uM; MCF7; HT_HG-U133A	NAGLU APC MAP3K6 BAHD1 RNF43 PKP3 PITX1 KMT2A RBM38	9.68e-06	200	155	9	5488_DN
Drug	Palmatine chloride [3486-67-7]; Down 200; 10.4uM; PC3; HT_HG-U133A	MAPT DBF4B APC SEC61A2 NCOR2 MAST4 LDB1 KMT2A BAHCC1	9.68e-06	200	155	9	6612_DN
Drug	Methylergometrine maleate [113-42-8]; Up 200; 8.8uM; MCF7; HT_HG-U133A	TCF3 APC ARID1A NCOR2 TLK1 TLE4 SIPA1L1 LTBP2 ARHGEF4	9.68e-06	200	155	9	3222_UP
Drug	Puromycin dihydrochloride [58-58-2]; Up 200; 7.4uM; PC3; HT_HG-U133A	ZNF219 HIVEP1 RPH3AL CDC42EP3 PGF RNF43 MAST4 CACNA1G	3.21e-05	179	155	8	6711_UP
Drug	Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A	ZMIZ1 ARID1A TLK1 PRDM10 KMT5B PITX1 SRRM2 ZNHIT2	3.48e-05	181	155	8	3643_DN
Drug	Lasalocid sodium salt [25999-20-6]; Down 200; 6.6uM; PC3; HT_HG-U133A	ZNF219 DBF4B APC DDN NUDCD3 KIAA0753 NCOR2 TLE4	5.29e-05	192	155	8	6639_DN
Drug	Naphazoline hydrochloride [550-99-2]; Down 200; 16.2uM; PC3; HT_HG-U133A	DBF4B NUDCD3 NCOR2 PRR14 LDB1 TLE3 KMT2A SRRM2	5.48e-05	193	155	8	6604_DN
Drug	Bambuterol hydrochloride [81732-46-9]; Down 200; 10uM; MCF7; HT_HG-U133A	TCF3 ZC3H12A MAPT BCL9 MAP3K6 MAST4 LDB1 SRRM2	5.89e-05	195	155	8	7239_DN
Drug	Phenazopyridine hydrochloride [136-40-3]; Down 200; 16uM; MCF7; HT_HG-U133A	TCF3 NAGLU TLE3 FAM222B SIPA1L1 SRRM2 ZNHIT2 PRRC2A	5.89e-05	195	155	8	6234_DN
Drug	Graveoline [485-61-0]; Up 200; 14.4uM; MCF7; HT_HG-U133A	ACAP1 MAPT IFI16 CDC42EP3 CACNA1G LYL1 SRRM2 TBX5	5.89e-05	195	155	8	4738_UP
Drug	Isoconazole [27523-40-6]; Down 200; 9.6uM; PC3; HT_HG-U133A	ZC3H12A MAP3K6 MAST4 TLE4 KMT2A TACC3 SRRM2 RBM38	6.11e-05	196	155	8	2056_DN
Drug	Cefadroxil [50370-12-2]; Up 200; 11uM; HL60; HT_HG-U133A	PSMB1 APC PLPPR3 IFI16 C2CD3 LDB1 DPEP2 BAHCC1	6.11e-05	196	155	8	1323_UP
Drug	Protriptyline hydrochloride [1225-55-4]; Down 200; 13.4uM; MCF7; HT_HG-U133A	VGF TCF3 ZNF219 RPH3AL NAGLU RTL10 MAST4 PITX1	6.11e-05	196	155	8	5438_DN
Drug	SB 202190; Up 200; 1uM; MCF7; HT_HG-U133A	ZC3H12A APC GON4L AHDC1 LHX1 SEC61A2 ARHGEF4 PLXNB1	6.11e-05	196	155	8	7054_UP
Drug	fluphenazine dihydrochloride; Down 200; 10uM; HL60; HT_HG-U133A	TCF3 ZNF219 MAPT AHDC1 TLK1 DPEP2 CACNA1G BAHCC1	6.11e-05	196	155	8	2697_DN
Drug	Stachydrine hydrochloride; Up 200; 22.2uM; HL60; HG-U133A	VGF DPH2 ACAP1 PPFIA1 ARID1A SEC61A2 KMT2A ZNHIT2	6.33e-05	197	155	8	1751_UP
Drug	LY 294002; Down 200; 0.1uM; HL60; HT_HG-U133A	DBF4B RTL10 PLPPR3 BAHD1 SLC4A2 KIAA0753 TLE3 PRRC2B	6.33e-05	197	155	8	6175_DN
Drug	Bacampicillin hydrochloride [37661-08-8]; Down 200; 8uM; PC3; HT_HG-U133A	TCF3 MAPT APC GON4L PRR14 SRRM2 PRRC2A PLXNB1	6.56e-05	198	155	8	4592_DN
Drug	Probucol [23288-49-5]; Up 200; 7.8uM; MCF7; HT_HG-U133A	ARID1A LHX1 NCOR2 TLK1 PITX1 ARHGEF4 PCDH1 PLXNB1	6.56e-05	198	155	8	3223_UP
Drug	fluphenazine dihydrochloride; Down 200; 10uM; HL60; HT_HG-U133A	TCF3 ZC3H12A PSMB1 RTL10 APC DDN IGLL5 RBM38	6.56e-05	198	155	8	6196_DN
Drug	Decamethonium bromide [541-22-0]; Down 200; 9.6uM; HL60; HT_HG-U133A	ACAP1 PPFIA1 NAGLU APC ARID1A BAHD1 TLE3 PRRC2B	6.80e-05	199	155	8	2933_DN
Drug	Vidarabine [5536-17-4]; Down 200; 15uM; MCF7; HT_HG-U133A	TCF3 HIVEP1 MAPT KIAA0753 LDB1 ZNHIT2 PRRC2A RABGGTB	6.80e-05	199	155	8	7203_DN
Drug	nordihydroguaiaretic acid; Down 200; 1uM; HL60; HT_HG-U133A	MAPT APC GON4L IFI16 AHDC1 NCOR2 KCNA3 BAHCC1	6.80e-05	199	155	8	2683_DN
Drug	Ceftazidime pentahydrate [78439-06-2]; Down 200; 6.2uM; PC3; HT_HG-U133A	TSPOAP1 MAPT NAGLU NUDCD3 ARID1A MAST4 TLE4 KMT2A	6.80e-05	199	155	8	5054_DN
Drug	Epirizole [18694-40-1]; Down 200; 17uM; PC3; HT_HG-U133A	ZC3H12A PPFIA1 GON4L EIF5B LYL1 SRRM2 ZNHIT2 MN1	6.80e-05	199	155	8	7292_DN
Drug	Iohexol [66108-95-0]; Up 200; 4.8uM; MCF7; HT_HG-U133A	TCF3 ARID1A CDC42EP3 BAHD1 TLE3 ARHGEF4 SRRM2 PRRC2A	7.04e-05	200	155	8	3322_UP
Drug	Todralazine hydrochloride [3778-76-5]; Down 200; 14.8uM; MCF7; HT_HG-U133A	DPH2 MAPT RTL10 APC RNF43 TLE3 PKP3 PRRC2B	7.04e-05	200	155	8	5512_DN
Disease	Colorectal Carcinoma	ACAP1 TCF3 NRCAM RBP3 APC PHETA1 GATA5 CORO1B ZMIZ1 ITPRID1 ARID1A RNF43 FAT1 LDB1 LONRF2	4.43e-06	702	154	15	C0009402
Disease	Malignant neoplasm of breast	ACAP1 NRCAM DLL4 ZMIZ1 ARID1A MAP3K6 CHRND LLGL1 JMJD6 TLE3 SIPA1L1 NLRC5 ARHGEF4 SPEN ZNHIT2 PRRC2A PLXNB1	4.88e-05	1074	154	17	C0006142
Disease	PR interval	PPFIA1 NCKAP5 ZMIZ1 PRR16 ZNF469 FAT1 COQ8A TLE3 SIPA1L1 CACNA1G TBX5	6.18e-05	495	154	11	EFO_0004462
Disease	orofaciodigital syndrome (is_implicated_in)	KIAA0753 C2CD3	8.09e-05	3	154	2	DOID:4501 (is_implicated_in)
Disease	neutrophil percentage of leukocytes	HIVEP1 TSPOAP1 MAPT ZMIZ1 ARID1A IFI16 PRR14 AATK COQ8A TLE4 NLRC5 SSBP4	9.13e-05	610	154	12	EFO_0007990
Disease	Colorectal Neoplasms	NRCAM APC PHETA1 GATA5 ZMIZ1 ARID1A RNF43 FAT1	1.09e-04	277	154	8	C0009404
Disease	osteoarthritis, hip, osteoarthritis, knee, total joint arthroplasty	NCOR2 TACC3 BRWD1	1.73e-04	21	154	3	EFO_0004616, EFO_0010726, EFO_1000786
Disease	cortical surface area measurement	ALX3 COL5A2 DCHS2 MAPT PPFIA1 APC NCKAP5 CNTLN MBD6 CDC42EP3 PGF ZNF469 MAST4 ADAMTS7 TLE4 GPR137B TACC3 PRRC2A	2.39e-04	1345	154	18	EFO_0010736
Disease	Polydactyly	ALX3 HOXA13 C2CD3 PITX1 TBX5	3.80e-04	117	154	5	C0152427
Disease	neuroimaging measurement	COL5A2 DCHS2 MAPT NAGLU APC NCKAP5 MBD6 CDC42EP3 ZNF469 ZBTB32 MAST4 TLE4 GPR137B TACC3 BAHCC1	4.97e-04	1069	154	15	EFO_0004346
Disease	brain measurement, neuroimaging measurement	COL5A2 DCHS2 NCKAP5 MBD6 CDC42EP3 PGF ZBTB32 MAST4 TACC3 BAHCC1	6.54e-04	550	154	10	EFO_0004346, EFO_0004464
Disease	Lymphoid leukemia	KMT2A LYL1	7.42e-04	8	154	2	C0023448
Disease	interleukin 2 receptor antagonist measurement	CDC42EP3 PRR16 ZNF469	8.07e-04	35	154	3	EFO_0008332
Disease	Burkitt Lymphoma	TCF3 ARID1A KMT2A	8.77e-04	36	154	3	C0006413
Disease	Mitral valve prolapse	LTBP2 MN1 TBX5	8.77e-04	36	154	3	HP_0001634
Disease	Carcinoma, Transitional Cell	ARID1A KMT2A TACC3	1.28e-03	41	154	3	C0007138
Disease	kidney cancer (implicated_via_orthology)	LLGL1 LATS2	1.44e-03	11	154	2	DOID:263 (implicated_via_orthology)
Disease	monocyte count	EEFSEC TCF3 ZC3H12A HIVEP1 TSPOAP1 NAGLU GON4L ZMIZ1 AHDC1 NCOR2 KCNA3 PIP5KL1 NLRC5 SSBP4 LYL1 MN1	1.52e-03	1320	154	16	EFO_0005091
Disease	Prostatic Neoplasms	NAGLU APC ARID1A RNF43 SLC4A2 JMJD6 PKP3 KMT2A ENPP5 SPEN	1.53e-03	616	154	10	C0033578
Disease	Malignant neoplasm of prostate	NAGLU APC ARID1A RNF43 SLC4A2 JMJD6 PKP3 KMT2A ENPP5 SPEN	1.53e-03	616	154	10	C0376358
Disease	Mitral valve prolapse, response to surgery	LTBP2 TBX5	1.73e-03	12	154	2	EFO_0009951, HP_0001634
Disease	electrocardiography	HIVEP1 ZMIZ1 KCNA3 MAST4 TLE3 SIPA1L1 CACNA1G RBM38 TBX5	1.94e-03	530	154	9	EFO_0004327
Disease	neurotic disorder	HIVEP1 MAPT AATK SIPA1L1	1.97e-03	101	154	4	EFO_0004257
Disease	Benign tumor of pancreas	APC RNF43	2.03e-03	13	154	2	C0347284
Disease	developmental disorder of mental health (implicated_via_orthology)	TCF3 NCOR2 PLXNB1	2.15e-03	49	154	3	DOID:0060037 (implicated_via_orthology)
Disease	L2 Acute Lymphoblastic Leukemia	TCF3 KMT2A TAL1	2.28e-03	50	154	3	C0023453
Disease	QRS amplitude, QRS complex	HIVEP1 MAPT TBX5	2.28e-03	50	154	3	EFO_0005054, EFO_0007742
Disease	Childhood Acute Lymphoblastic Leukemia	TCF3 KMT2A TAL1	2.55e-03	52	154	3	C0023452
Disease	prostate carcinoma	EEFSEC GATA5 ZMIZ1 CDC42EP3 RNF43 KCNA3 MAST4 DPEP2 TSHZ1 SPEN EPHA10 TBX5	2.56e-03	891	154	12	EFO_0001663
Disease	corneal topography	RBP3 CHRND ZNF469 ADAMTS7	2.60e-03	109	154	4	EFO_0004345
Disease	African Burkitt's lymphoma	TCF3 ARID1A	2.72e-03	15	154	2	C0343640
Disease	unipolar depression, response to escitalopram, response to citalopram, mood disorder	CORO1B TLE3	2.72e-03	15	154	2	EFO_0003761, EFO_0004247, EFO_0006329, EFO_0007871
Disease	Burkitt Leukemia	TCF3 ARID1A	2.72e-03	15	154	2	C4721444
Disease	anemia (implicated_via_orthology)	APC SLC4A2	2.72e-03	15	154	2	DOID:2355 (implicated_via_orthology)
Disease	neuroticism measurement, cognitive function measurement	HIVEP1 APC DDN ARID1A STAB1 AATK SIPA1L1 IGSF9B LONRF2	3.00e-03	566	154	9	EFO_0007660, EFO_0008354
Disease	mean reticulocyte volume	MAPT BAHD1 ZNF469 LDB1 DPEP2 ENPP5 TACC3 LYL1 TAL1 MN1 RBM38	3.25e-03	799	154	11	EFO_0010701
Disease	atrial fibrillation	MAPT ZMIZ1 NCOR2 TLE3 PITX1 SPEN TBX5	3.44e-03	371	154	7	EFO_0000275
Disease	age at first birth measurement	SIPA1L1 IGSF1 LONRF2 PRRC2A	3.67e-03	120	154	4	EFO_0009101
Disease	colorectal cancer (is_implicated_in)	TCF3 APC RNF43 FAT1	3.78e-03	121	154	4	DOID:9256 (is_implicated_in)
Disease	triglycerides to total lipids in large HDL percentage	ARID1A NCOR2 NLRC5	3.84e-03	60	154	3	EFO_0022330
Disease	Feeding difficulties	ZMIZ1 MN1	3.92e-03	18	154	2	C0232466
Disease	Female Urogenital Diseases	LHX1 HOXA13	3.92e-03	18	154	2	C1720887
Disease	Precursor Cell Lymphoblastic Leukemia Lymphoma	TCF3 KMT2A TAL1	4.02e-03	61	154	3	C1961102
Disease	Pancreatic carcinoma	APC RNF43	4.37e-03	19	154	2	C0235974
Disease	hippocampal tail volume	ITPRID1 MAST4	4.37e-03	19	154	2	EFO_0009398
Disease	intrahepatic cholangiocarcinoma (is_marker_for)	ARID1A RNF43	4.37e-03	19	154	2	DOID:4928 (is_marker_for)
Disease	cerebellum white matter volume change measurement, age at assessment	ADAMTS7 FOXF1	4.83e-03	20	154	2	EFO_0008007, EFO_0021498
Disease	seborrheic dermatitis	TNRC18 MAST4	4.83e-03	20	154	2	EFO_1000764
Disease	attention deficit hyperactivity disorder, autism spectrum disorder, intelligence	SEPTIN4 MAPT DDN LDB1 IGSF9B LONRF2 BRWD1	5.04e-03	398	154	7	EFO_0003756, EFO_0003888, EFO_0004337
Disease	monocyte percentage of leukocytes	ACAP1 TSPOAP1 ZMIZ1 ARID1A KCNA3 COQ8A TLE3 SSBP4 LYL1 BAHCC1	5.17e-03	731	154	10	EFO_0007989

Protein segments in the cluster

Peptide	Gene	Start	Entry
TNRKGPMHGSDFPPR	nan	261	Q6ZR03
PELLHMSRPAEDGPS	CHRND	356	Q07001
SDPHVTEPLMGGVPE	SLC4A2	461	P04920
MDGRDFAPPPHLLSE	BAHCC1	1	Q9P281
SEGGLPHSPPMRLQA	ADAD2	356	Q8NCV1
RADGFPEMPHSPAQT	C1orf140	56	Q5VVS0
ISGPLFPVDTRGPFM	CTAGE4	701	Q8IX94
ISGPLFPVDTRGPFM	CTAGE9	701	A4FU28
GAAPAHAPLLSAPMG	CNTLN	71	Q9NXG0
VAGFMGVPAPSAAHP	ALX3	281	O95076
PAERGPLAGHMPSSR	RTL10	76	Q7L3V2
PEHTPGTAMPDGALD	ARHGEF4	136	Q9NR80
RPAMAPGSSHLGAPA	CORO1B	416	Q9BR76
PLGRGTMPGKFPHSD	DLL4	621	Q9NR61
VGSLSPEPMPLERFG	DPH2	186	Q9BQC3
FRASGHPPSLPTMAD	ACAP1	576	Q15027
LGPMAEPHPEDTFTV	AHDC1	1586	Q5TGY3
QHHPLGPTDMGRGEP	CEP170B	1011	Q9Y4F5
MLDGPLFSEGPDSPR	DDN	1	O94850
LSPDMISPPLGDFRH	CDC42EP3	26	Q9UKI2
FLPTTLTGLGHMPEP	ADAMTS7	1336	Q9UKP4
FGMTPVLPAFAGHVP	NAGLU	236	P54802
SAGFPRPLAAPGAMH	RBM38	11	Q9H0Z9
AKMASTPHPPGARGT	QPCT	221	Q16769
PPASPSREMAKGSHE	TSPOAP1	1131	O95153
SREMAKGSHEDPPAP	TSPOAP1	1136	O95153
LDGSPDPAHSMGPDT	LLGL1	986	Q15334
RPMDGTYGPPAKRHE	ARID1A	1371	O14497
SIHPPRDMPAAGSLG	FAT1	4461	Q14517
GRTFPPVHPLDVMAD	NCOR2	1481	Q9Y618
PGEGASPQMFHTVSP	MBD6	126	Q96DN6
ALSPGAPTPRELMHG	PARP15	11	Q460N3
VMGPPRSGTGIHIDP	JMJD6	176	Q6NYC1
MDHPPTGPPSRDDFS	PIP5KL1	71	Q5T9C9
HMDEPSSPSRPGLDR	MAJIN	66	Q3KP22
GNAFPPFHPGTMLDR	LDB1	26	Q86U70
PFHPGTMLDRDVGPT	LDB1	31	Q86U70
LLVSGRHPSMPAFPA	NCKAP5L	1186	Q9HCH0
HPSDRMGFPPGAAQA	NUDCD3	46	Q8IVD9
PEPAVVMGHSGEDLP	NRCAM	831	Q92823
HPGMAPRTVFPPDDG	ITPRID1	976	Q6ZRS4
FGADGPTALEEMPRP	LATS2	196	Q9NRM7
PGKDDAVPDLMGPHS	KMT5B	636	Q4FZB7
EMATGRPPFHELGSP	MAP3K6	841	O95382
GGDLHFPADRMPPGA	MGAT5B	101	Q3V5L5
EDPTMPFRHKPGSVF	PLXNB1	1386	O43157
PALGPDGSALFDMVP	PCDHGB1	561	Q9Y5G3
PRMEHLRHSPGPGGQ	PCDH1	21	Q08174
HLGPDSPLMGPVISD	ENPP5	196	Q9UJA9
LAMPFHGGQPTGAPL	FAM222B	471	Q8WU58
GRELPPDMTVVPGDH	KCNA3	46	P22001
PHLGSVPDFRFPMAD	PPFIA1	526	Q13136
LPGPLHSMSAEVFGP	LHX1	361	P48742
GLPGTLHPMPGEVFS	LHX5	356	Q9H2C1
PSDMSHPGSLEPARE	GOLGA6L7	556	A0A1B0GV03
LSHFGVMPDREPEPQ	LONRF2	676	Q1L5Z9
GPGEPDPMLSTHTQL	PRDM10	811	Q9NQV6
VAHSEGEPGSPPRMH	EPHA10	241	Q5JZY3
PALGPDGSALFDMVP	PCDHGB5	561	Q9Y5G0
SHSAPDPDGLPHFME	GORASP1	276	Q9BQQ3
MGPDGPGPVLTLFSH	NLRC5	316	Q86WI3
VSGMLEHGGLTPPPA	POU3F4	141	P49335
SPRGMHRDGNTLPSP	NUTM1	546	Q86Y26
SPIPYHLGSLPEGMT	DCHS2	3311	Q6V1P9
HLGSLPEGMTPNFSP	DCHS2	3316	Q6V1P9
RPGDMVDPFHTLFGI	RABGGTB	281	P53611
GRDPAGMPHPETGKD	PAPSS1	521	O43252
GGTPRPIEMHSHDPL	COG6	291	Q9Y2V7
SFLHAPGAGSPMFVP	GATA5	21	Q9BWX5
HGLLRPMVAPQSGDP	IGLL5	36	B9A064
TAHPGPIMAPGESLN	IGSF1	231	Q8N6C5
PPPLEETSNGGRMLH	C2CD3	2021	Q4AC94
EPGAAHEMKSPPSAR	CACNA1G	1076	O43497
TRPPDTHQDMARGPG	LINC00315	71	P59091
DGEPSPRSAAHTMPR	DBF4B	281	Q8NFT6
PMHLGAVPVYRGSPS	FUT11	296	Q495W5
GPQGHRDVPFSPDEM	BCL9	431	O00512
DVSMPPLHRGVGTPA	C3orf20	256	Q8ND61
ELVGSSPHREASPMP	GON4L	1891	Q3T8J9
SPHREASPMPGAKEA	GON4L	1896	Q3T8J9
PPPEETYSLHRKMGG	COQ8A	601	Q8NI60
PEHLQGGRSPSMHEP	BAHD1	671	Q8TBE0
HPGPDGLSRPFSAQM	COL5A2	181	P05997
HMHYLPEEPGPGGRD	ATG9B	596	Q674R7
SAFAALHRGRPPEMP	BRWD1	126	Q9NSI6
MSEAPTGDHAPAPTR	LTBP2	1396	Q14767
HFPGPFMTSIGPAES	IFI16	466	Q16666
SHFPGPFMTSIGPAE	IFI16	521	Q16666
GHSRPPGVAMPTTEL	LYL1	66	P12980
KGPHPTARSPGTVME	MAST4	1901	O15021
LGAPRAHTMPGTYAP	DPEP2	46	Q9H4A9
LLSPGVDPTPEGHMT	KMT2A	2976	Q03164
SHEDPNRMTGGPRAP	EMILIN3	206	Q9NT22
PGRDLGMEPHRAAGP	PSMB1	11	P20618
ELHAELGMKPPSPGT	OTUD5	466	Q96G74
PGEAPSGHFDMFSPS	MN1	236	Q10571
VEAPRMGFTHPPGHL	RPH3AL	246	Q9UNE2
DLTNPGMVPSHGFSP	GPR137B	321	O60478
SPLLPTGAGGVMEPH	FOXF1	246	Q12946
DMGPAFHLARPADPR	PITX1	26	P78337
GEDPPMPASRGSYHL	TACC3	391	Q9Y6A5
RASAPHGPLDMAPFA	PHETA1	211	Q8N4B1
NGMLSVPAPGVPHSD	SRRM2	2491	Q9UQ35
FQARMPDSGPLPETH	VGF	231	O15240
SPPESMGAIFEDPVH	SEC61A2	346	Q9H9S3
SPFGHGLRPLDVEFM	SEPTIN4	261	O43236
MPGRLYVHPDSPATG	TBX5	131	Q99593
SLAMEPLLGHGPPVD	AATK	571	Q6ZMQ8
MLESLPSVGRPSGHP	NCKAP5	1331	O14513
HPGLVEPADGAMPSF	CCDC51	346	Q96ER9
SLHPAMLPAADGAGP	TAL1	316	P17542
IEPIPGESPKMFGRH	EIF5B	1161	O60841
HLPPFPLENGGMGIS	PRR16	256	Q569H4
RHTVGGGEMARAPPP	PRR14	361	Q9BWN1
GLSSDPHFEEPGPMV	PRRC2A	1526	P48634
LPDTVDGQLPMGPHS	PRSS47P	36	A8MTI9
LPSQEPGMGPRHHRF	RNF43	376	Q68DV7
PPSQGPSYHDTRRMG	SLTM	971	Q9NWH9
MAPVGPPRSEGSHHI	SIPA1L1	51	O43166
IMGAAHEPSPPGGLD	ST6GAL2	61	Q96JF0
RAPLFVPPGMQHSIG	KIAA0753	886	Q2KHM9
PGESRHEPLGLPMES	HOXA13	261	P31271
MLPSGEGGPKRTHPT	ARNTL	466	O00327
PQKHVSFTPGDDMPR	APC	1626	P25054
HSVRICMSPGPEPGE	CNGB1	1221	Q14028
MELPSGPGPERLFDS	AUP1	1	Q9Y679
PMPTRPVSFHERGGV	PKP3	156	Q9Y446
GLGPPSLHQGMAPAF	TNRC18	821	O15417
SLHQGMAPAFPPGLG	TNRC18	826	O15417
NHTPPSGRPREGAMD	TLK1	36	Q9UKI8
PTRDPSGPFLMSVDH	EEFSEC	216	P57772
APVLDMAPAGHPEGD	USP42	901	Q9H9J4
NDKFMPPDDPLGRHG	ZC3H12A	271	Q5D1E8
AGPRHLPSMAPGDSS	ZBP1	226	Q9H171
MDLRHNPGGPSSAVP	RBP3	476	P10745
SFLAPGMPDPSLHAS	TIAM2	266	Q8IVF5
GMPDPSLHASFPPGD	TIAM2	271	Q8IVF5
HPGSMPVIDDRPADA	SPEN	2786	Q96T58
ESMVRGHRPVSPAPG	RLF	31	Q13129
GDPQMVLSAPHPGLS	TCF3	631	P15923
PTPFGIVPHAGMNGE	TLE4	371	Q04727
GRPEFPFGGLETPAM	IGSF9B	1041	Q9UPX0
DASPGHLRAPAEPMA	PLPPR3	426	Q6T4P5
RHSPGRQSPDMPGDF	PGF	131	P49763
LLPGAMEPSPRAQGH	SSBP4	176	Q9BWG4
PHPADPGMETGEALS	TNKS1BP1	1421	Q9C0C2
ASMPGSHLPPLYLDG	PRRC2B	1916	Q5JSZ5
HVPLEGPMLEAPGRS	STAB1	1231	Q9NY15
FLREPGPPGLSHQLM	MAPT	136	P10636
SSPHSLVPMGPGREH	PRR33	131	A8MZF0
NDKFMPPDDPLGRHG	ZC3H12B	326	Q5HYM0
VSFGAVGFDPHPPMR	TLE3	416	Q04726
DRFMPPDDPLGRHGP	ZC3H12D	226	A2A288
PMLPSHFPDLSGGKV	ZNF469	1481	Q96JG9
HPPGPLGTRGAMHEV	ZNHIT2	276	Q9UHR6
HRMQNGFGSPEPSLP	ZNF687	121	Q8N1G0
HKHSPPRGRPEMAGA	ZBTB32	166	Q9Y2Y4
NDKFMPPDDPLGRHG	ZC3H12C	381	Q9C0D7
MAGVPGPATVEHRPL	PRRT1B	171	A0A1B0GWB2
PTFEGHIEICPPGMS	PPP6R3	281	Q5H9R7
QLSMLIPGPGFSRHP	ZMYND15	406	Q9H091
KVAMREPEHSPVPGG	HIVEP1	991	P15822
GIIMDHSPEPSFINP	TSHZ1	731	Q6ZSZ6
MEGSRPRAPSGHLAP	ZNF219	1	Q9P2Y4
EPHFLPDAMFGQPGA	YTHDF2	96	Q9Y5A9
RPPGISPFGTHGQRM	ZMIZ1	371	Q9ULJ6
SSPHMKPAPVGSRGR	ZNF326	161	Q5BKZ1
MTLPHSLGGAGDPRP	MYOM3	1	Q5VTT5